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This dissertation is presented in article-format. The first chapter serves as a review of literature 
relevant to the thesis topic, while the second chapter reports on results obtained from various 






Chapter 1:                                    
The Endothelium: An Essential 
Barrier Between Chronic Stress 





In recent years, chronic stress has emerged as an influential and understudied risk factor for the 
onset of cardiovascular disease. While much is known regarding the physiological systems that 
orchestrate the innate stress response, limited knowledge exists regarding the molecular 
derangements that underpin cardiovascular pathologies. Endothelial integrity is essential for 
maintaining a stable internal environment. Stress-mediated cardiovascular, metabolic and 
immunologic alterations negatively impact the vaso-reactive capabilities of the endothelium. 
Furthermore, chronically elevated circulating levels of glucocorticoids and catecholamines not 
only directly influence nitric oxide availability but further contribute towards a proinflammatory and 
prooxidative state. A dysfunctional endothelial layer in turn facilitates the development of stenotic 
and atherosclerotic vascular lesions. This review highlights the current burden of chronic stress 
globally and in South Africa. We subsequently discuss the activity and regulation of the 
hypothalamic-pituitary-adrenal axis and the sympathetic nervous system following exposure to 
acute and chronic stressors. Lastly, we focus on mechanistic avenues that contribute towards 





Chroniese stres het onlangs as ’n belangrike risiko-faktor vir kardiovaskulêre siektes aan lig 
gekom. Alhoewel daar reeds heelwat kennis bestaan oor die fisiologiese stelsels wat die 
stresrespons reguleer, is daar beperkte kennis aangaande die molekulêre afwykings van 
kardiovaskulêre patologie. Endoteel integriteit is noodsaaklik vir die handhawing van 'n stabiele 
interne omgewing. Stres-gemedieërde kardiovaskulêre, metaboliese en immunologiese 
veranderinge het 'n negatiewe invloed op die vaso-reaktiewe vermoëns van die endoteel. Verder 
beïnvloed chronies verhoogde vlakke van glukokortikoïede en katkolamiene in die sirkulasie nie 
net die beskikbaarheid van stikstofoksied nie, maar dra dit ook tot 'n pro-inflammatoriese en pro-
oksidatiewe toestand by. Op sy beurt fasiliteer ’n disfunksionele endoteel die ontwikkeling van 
stenotiese- en aterosklerotiese vaskulêre letsels. Hierdie resensie beklemtoon die invloed van 
chroniese stres op Suid-Afrika. Hieropeenvolgend, word die werking en regulering van die 
hipotalamus-pituïtêre-bynier-as en die simpatiese senuweestelsel na die blootstelling aan akute 
en chroniese stressors bespreek. Ten slotte word daar op die meganistiese weë wat tot die 






A large body of evidence supports the role of chronic stress in potentiating the development of 
numerous diseases. These range from metabolic conditions such as diabetes and obesity to 
depression, anxiety and other psychiatric disorders. Recent evidence implicates chronic stress 
as a key risk factor for the onset of cardiovascular disease (CVD) which is of particular concern 
given the global prevalence of such disorders.  
Innate stress-response mechanisms are activated following exposure to harmful stimuli. Over 
millions of years, such systems evolved to adequately prepare the body against a variety of 
stressors, i.e. by increasing energy availability and upregulating host defense mechanisms. 
However, drastic changes accompanying modern-day living conditions mean that most external 
stressors are neither transient nor physical, thus limiting the capability of the body’s inherent 
stress response to chronic psychosocial stressors.  
It is well established that the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic 
nervous system (SNS) function as the primary effectors of the innate stress response. However, 
the underlying stress-mediated molecular pathologies driving CVD progression are yet to be fully 
elucidated. In recent years, the endothelium has emerged as a particularly susceptible target of 
glucocorticoid and catecholamine action. This review highlights the current burden of stress in 
South Africa (SA), as well as the role of chronic stress in potentiating CVD onset. It provides a 
comprehensive overview of the highly integrated stress response before focusing on the potential 





2. Chronic stress: an important component of psychiatric disorders and CVD 
Poor mental health constitutes a large portion of the noncommunicable global burden of disease 
(World Health Organization, 2018). During 2015, mental disorders were directly responsible for 
17.3 million years lived with disability and 8.6 million years of life lost, amounting to  232,000 
deaths (Sorsdahl et al., 2018). Depression is the most prevalent 12-month and lifetime disorder 
in SA, with the Western Cape boasting the highest prevalence rates (Quirk et al., 2013; Whiteford 
et al., 2015). During 2009, the South African Stress and Health study revealed that 1 in 17 
Nigerians present with an anxiety or mood disorder, compared to approximately 1 in 6 South 
Africans (Herman et al., 2009). This correlates with a more recent survey that ranked SA and 
Nigeria as the most stressed countries in the world, using data sourced from the International 
Monetary Fund, the United Nations Office on Drugs and Crime, Transparency International, the 
Central Intelligence Agency World Fact Book and the World Health Organization (Bloomberg, 
2013). Stress levels were estimated using the following parameters: income inequality, homicide 
rates, unemployment, life expectancy, corrupt perception, urban air pollution, gross domestic 
product per capita and purchasing-power-parity basis (Bloomberg, 2013). Although chronic stress 
is a key component of poor mental health, it is also highly prevalent in those of the “otherwise-
healthy” global population (Ross et al., 2017; Yousaf et al., 2019). This highlights the current 
burden of poor mental health in SA and why it is essential to gain greater mechanistic insights 
into the pathological implications of chronic stress.  
2.1 Chronic stress and disease 
Stress can be defined as the body’s generic response to intrinsic or extrinsic stimuli that threaten 
to overwhelm its ability to maintain homeostasis (Johnson et al., 1992; McEwen, 2005). Should 
the stress response be chronically upregulated, damaging and debilitating effects may ensue if 
excessive and un-checked autonomic and adrenocortical function are not prevented. Although 




These include a) the type of stressor (emotional or physical), b) history of early-life stress (ELS) 
and c) the presence of comorbidities (Johnson et al., 1992; Brosschot, 2010). Emotional stressors 
continuously challenge homeostasis, emphasizing that adequate physiological and behavioral 
competence is crucial for maintaining a healthy mental state (Agorastos et al., 2018). 
Psychological stressors can be further categorized into two domains: environmental and 
emotional influences. The former refers to low socioeconomic status, family or job stress, 
traumatic life experiences and low social support. Emotional factors include anxiety, depression 
and fear (Yammine et al., 2014). Research indicates that the magnitude of the mounted response 
as well as the ability to recover from various stressors, is dependent on the individual’s perception 
of the stressors rather than the stressor itself. The perception of a stressor(s) is further influenced 
by a) novelty of the stressor, b) its unpredictability, c) degree of threat to a person or ego and d) 
the sense of loss of control. Patient characteristics are also profoundly influential and include age, 
gender and personality traits (Guilliams and Edwards, 2010).  
Adverse exposures during neonatal, childhood and adolescent life drastically increase the risk of 
developing stress-mediated psychiatric disorders (van Bodegom et al., 2017). Here studies 
demonstrate that the frequency, duration, degree and presence of other contributing risk factors 
(e.g. drug addiction and poverty) corresponds with disorder complexity and severity (Scott, 2011; 
Reuben et al., 2016).  Approximately 30-40% of the global adult population have experienced 
ELS, which includes maltreatment, parental separation and abuse (Agorastos et al., 2018). Early-
life stress exposure during juvenile brain development is linked to a poorer adaptability to 
stressors in adult life as well as elevated susceptibility to cardiovascular and neurological 
diseases (Chrousos, 2009; Scott, 2011). Given large socioeconomic disparities, high poverty 
rates and poor access to quality healthcare, the SA population is particularly susceptible to the 




be conceptualized as an independent risk factor for various cardiovascular, metabolic and 
inflammatory conditions (Korkeila et al., 2010; Agorastos et al., 2018).  
2.1.1 Chronic stress and CVD 
Despite reductions in global incidence rates, CVD persists as the primary source of 
noncommunicable deaths (World Health Organization, 2018). Aside from the traditional CVD risk 
factors, recent studies implicate chronic stress as an important driver of CVD, diabetes and 
metabolic syndrome onset (Lagraauw et al., 2015; Brunner, 2017; Esler, 2017; Sgoifo et al., 2017; 
Wood and Valentino, 2017). Epidemiological studies such as the INTERHEART study (n = 29,972 
participants from 52 countries) and the INTERSTROKE study (n = 26,919 participants from 32 
countries) both recognized psychosocial stress as one of ten modifiable risk factors for the onset 
of heart disease and stroke (Rosengren et al., 2004; O’Donnell et al., 2016). Moreover, behavioral 
risk factors such as poor nutrition, a sedentary lifestyle as well as hazardous alcohol and tobacco 
use are all exacerbated by poor mental health (Dimsdale, 2008; Sorsdahl et al., 2018).  
Experimental evidence indicates that stressed persons are more likely to consume calorie-rich 
foods with high levels of sugar, salt and saturated fats (Penninx, 2017). This is concerning as 
approximately 37% of the adult SA population are physically inactive, with 24% of all adults 
presenting with raised blood pressure and 27% regarded as clinically obese (World Health 
Organization, 2014).  Within the SA context, data revealed that psychologically distressed 
individuals exhibited an increased prevalence of hypertension (15.7%) and diabetes (15.0%), both 
prominent risk factors for CVD onset (Sorsdahl et al., 2018). 
Sources of chronic life-stressors are varied and include interpersonal conflict, financial troubles, 
personal worries and work-related stressors (Wilson et al., 2014).  Moreover, a meta-analysis (n 
= 47,045) found that work stress was associated with poor lifestyle behaviors and diabetes, both 
of which are important contributors of CVD development (Nyberg et al., 2013; Kivimäki and 




increased risk of developing CVD (Steptoe and Kivimäki, 2013; Cohen et al., 2015). A similar 
pattern holds for the SA population as approximately 36% of persons between the ages of 15 to 
29 are not employed, educated or participating in any formal training (Lannoy and Mudiriza, 2019). 
As this trend has persisted since 2013, it highlights the desperate state a large proportion of South 
Africans experience and emphasizes the detrimental burden of chronic life-stressors on the SA 
population.  
A number of studies have examined the effects of chronic stress on endothelial function (Table 
1). In the context of CVD, healthy endothelium is crucial for the prevention of atherosclerosis and 
other vascular pathologies (Bonetti et al., 2003). Participants of these studies most commonly 
suffered from stressors pertaining to occupational challenges and the burden of prolonged care 
for loved ones with dementia (Table 1). Two distinct methods can be employed to assess in vivo 
human endothelial function. The first method involves measuring fluctuations in blood flow or 
artery diameter following administration of an endothelium-dependent vasodilator. Flow-mediated 
dilation (FMD) is an alternative technique used to assess shear-stress induced changes in arterial 
calibre after a transient period of forearm ischemia (Golbidi et al., 2015). Subsequent to periods 
of chronic stress, subjects typically present with impaired FMD as well as increased expression 
of markers of endothelial activation and damage (Table 1). 
2.1.2 Depression and CVD 
Stress-related psychiatric disorders, such as depression and anxiety, display largely identical 
neurobiology and thus present with similar symptoms (Hill et al., 2012; Vaccarino and Bremner, 
2017). Depression is the leading worldwide cause of disability and is a major contributor to the 
overall global burden of disease (World Health Organization, 2018). Many studies illustrate the 
impact of depression on somatic health and CVD risk (Penninx, 2017). A meta-analysis and 
systematic review integrating longitudinal evidence from 1,608 articles concluded that depression 




disorder being the strongest predictor for CVD morbidity and mortality (Van der Kooy et al., 2007; 
Doyle et al., 2015). Furthermore, subclinical manifestations of CVD such as atherosclerosis, 
impaired endothelial function, aortic calcification and arterial stiffness are upregulated in 
depressed individuals (Penninx, 2017). Another study (n = 52,095) found that depression and 
post-traumatic stress disorder (PTSD) were independently associated with heart disease (Scott 
et al., 2013). Depressed individuals who are saddled with CVD are at a higher risk of recurrent 
cardiovascular complications and mortality (Bartoli et al., 2013; Towfighi et al., 2017).  The 
depression-associated CVD risk could be due to an unhealthy lifestyle, biological dysregulation, 
early-life trauma, personality traits and genetic vulnerability (Penninx, 2017). It is well documented 
that depressed individuals consistently consume larger quantities of alcohol and smoke more than 
non-depressed persons (Penninx, 2017). Additionally, depressed persons are more likely to 
exhibit higher caloric intake, less frequently engage in physical activity and are more likely to 
present with certain vitamin deficiencies (Penninx et al., 2011). 
Chronic hyperactivation of the HPA axis in clinically depressed individuals is one of the most 
concrete findings of psychiatric research (Tsigos and Chrousos, 2002). Other biological 
dysregulations include increased sympathetic tone with subsequent cardiac outcomes 
(arrythmias, hypertension, increased heart rate variability) (Licht et al., 2013) and metabolic 
dysregulation (hyperglycemia and hypercholesterolemia) (Vogelzangs et al., 2014). A 
dysfunctional immune response - characterized by elevated levels of circulating inflammatory 
mediators - is also associated with depression to further increase CVD risk (Penninx et al., 2011; 




Table 1: Summary of studies investigating chronic stress and endothelial dysfunction.  MESA – Multi-ethnic Study of 
Atherosclerosis; ICAM-1 - intercellular adhesion molecule-1; FMD – flow-mediated dilation; sTF - soluble tissue factor; VWF - von 
Willebrand factor. 
Study design Stressor characteristics Parameters Findings Reference 
Multi-ethnic sample 
of adults (45-84 
years) from the 
MESA.  
Participants questioned 
on financial, job, 
relationship or health-
related issues spanning 
the previous 6 months. 
FMD (n = 2,963); 
ICAM-1 (n = 2,523); 
E-selectin (n = 971). 
Chronic stress associated with lower 
absolute FMD after adjusting for 
demographic, socioeconomic, behavioral 
and biological risk factors. ICAM-1 but 






of adults (mean age: 
56.1 ± 0.21; 55% men; 
41.2% white) (n = 
1,499) from the 
MESA.  
Stress associated with 
work-hours, job control, 
job strain and 
occupational category.   
FMD. FMD was only positively correlated with 
work-hours before adjustment for age, 
gender and CVD risk factors. FMD was 
associated with occupational category; 
with management and sales presenting 






between FMD and job strain, job control 
or job demands were observed. Although 
race had no influence on any 
correlations, gender modified the 
association between FMD and 
occupational stress.  
Elderly caregivers 
(Mean age = 74.3 ± 




Stress attributed to 
prolonged caregiving. 
FMD.  Positive association found between 
leisure satisfaction and FMD. Negative 
relationship found for stress and FMD. 
Depressive symptoms were not 
associated with FMD. Time and number 
of years of caregiving was a significant 





providing care for 
demented and 
Stress as a result of 
prolonged caregiving. 
FMD. Participants caring for partner with 
moderate to severe dementia presented 
with significantly worse FMD than those 








partners (n = 78). 
and non-caregivers. Furthermore, the 
number of years of caregiving was 
related to severity of FMD deterioration.   
Caucasians (n = 804) 
from the Survey of 
Midlife in the United 
States 
Chronic stress stemming 
from discrimination.  
Serological E-
selectin. 
Women reported a greater number of 
instances of major and everyday 
discrimination than men. For men, major 
and everyday discrimination was 




PTSD (n = 14) and 
non-PTSD age- and 
gender-matched 
controls (n = 14).  
Stress associated with 
PTSD (re-experiencing, 
avoidance, arousal). 






Patients with PTSD had higher sTF and 
VWF levels, with no association found 










2.2 Synopsis  
Chronic stress represents an important mental health issue as it is associated with the onset and 
progression of various diseases. More recently, a large body of evidence supports a role for 
chronic stress in mediating CVD onset. This is alarming considering the already devastating 
burden of CVDs on SA’s health, well-being and economic productivity (Hofman, 2014). Given the 
high prevalence of stress amongst South Africans, coupled with poor quality of healthcare, lack 
of education and extreme poverty, this population is particularly susceptible to the burden of 
chronic stress and its associated pathologies. This emphasizes the need for the research and 
development of more effective coping strategies and a push for encouraging the youth to 
implement these strategies from a younger age.  
The next section provides a comprehensive overview of stress-response mechanisms and how 
they function to preserve homeostasis. Maladaptions of these systems following exposure to 





3. The major stress-response mechanisms 
3.1 Brief history of stress research 
Although the concept of maintaining a stable internal environment dates back to Greek 
philosophers such as Empedocles and Hippocrates (Garrison, 1929; Adams, 1939), it was Walter 
Cannon who coined the term “homeostasis” in the early 1900s. He demonstrated that emotional 
and physical stimulants induced a similar response and that this was partly facilitated by the 
sympathoadrenal axis (Cannon, 1929). Almost 30 years later, the “General Adaptation Syndrome” 
theory was put forth by Hans Selye (Selye, 1936; Szabo et al., 2012).  With this theory, Selye 
pioneered the field of stress biology and highlighted the importance of the HPA axis in maintaining 
this stable internal milieu (Szabo et al., 2012). In 1948, a former student of Selye proposed that 
the function of the anterior pituitary gland was modulated by factors released from the 
hypothalamus (Harris, 1948). This factor was then named corticotropic releasing hormone (CRH) 
in 1955 (Saffran, Schally and Benfey, 1955). Current research is directed towards elucidating the 
downstream negative effects of a chronically upregulated stress response and how such 
maladaptions can lead to pathophysiologic outcomes and disease onset.  
3.2 The integrated stress response 
Appropriate basal activity of the stress system is important for a sense of well-being, efficient 
performance of tasks and positive social engagements (Chrousos, 2009). Inadequate 
responsiveness of the stress response (in terms of both duration and magnitude) may impair 
growth and development and also contribute to endocrine, behavioral, cardiovascular, metabolic 
and immune disorders (Yousaf et al., 2019). The stress-mediated progression of such conditions 
is reliant upon the genetic vulnerability or resilience of an individual to stress, their exposure to 
traumatic events during juvenile development as well as the severity, duration and timing of the 




Allostasis can be defined as the process of maintaining homeostatic stability with the help of 
various physiological regulatory systems that regulate the release of hormones and other 
mediators (Seeman et al., 2001). The perpetual upregulation of this response results in 
physiological wear and tear, particularly following impaired negative feedback inhibition. This 
concept is known as allostatic load and can lead to alterations in various neuroendocrine set-
points. Although such adaptions confer immediate benefits, they can also elicit deleterious effects 
in the long-run (McEwen, 1998, 2005).  Sustained allostatic overload therefore results in a 
maladaptive stress response, psychological disturbances and metabolic dysregulation (Golbidi et 
al., 2015).  Although the links between poor mental health and CVDs are yet to be elucidated, 
upregulation of the HPA axis and SNS is paramount.  The following sections review the activity 
of these systems following exposure to acute and chronic stressors.  
3.2.1 HPA axis 
Acute response 
Activation of the HPA axis begins with the release of CRH from hypophysiotropic neurons of the 
hypothalamus (Johnson et al., 1992; Burford et al., 2017). This hormone is then transported to 
the anterior pituitary gland via hypophyseal portal vessels where they stimulate the release of 
ACTH (Figure 1). This hormone then binds to melanocortin type 2 receptors in the adrenal cortex 
which in turn triggers the release of cortisol (corticosterone in animals) from the zona fasciculata 
and the zona reticularis (Charmandari et al., 2005). Glucocorticoids largely exert metabolic effects 
that mobilize biochemical resources to aid in the “fight-or-flight” response. Aside from its 
hyperglycemic affects, cortisol also acts on the hypothalamus and anterior pituitary as part of a 
negative feedback mechanism to inhibit the secretion of CRH and ACTH (Figure 1) (Burford et 





Figure 1: The integrated stress response. CRH – Corticotropic-releasing hormone; ACTH – 
Adrenocorticotropic hormone.   
Corticotropic-releasing hormone is a 41 amino-acid peptide and was isolated and characterized 
by Vale in 1981 (Vale et al., 1981). This peptide hormone is produced in the neuronal cell bodies 
of the paraventricular nucleus. Corticotropic-releasing hormone receptors are not only found in 
the hypothalamus but are also present in the limbic system, the basal forebrain and locus 
coeruleus-norepinephrine (LC-NE) system of the brainstem; indicating the broad regulatory role 
of this peptide in the stress response (Charmandari et al., 2005).  Corticotropic-releasing hormone 
binds to two receptors, namely CRH receptor-1 and CRH receptor-2 (CRHR1 and CRHR2) 
(Deussing and Chen, 2018). Although both are G protein-coupled receptors, CRHR1 is 




(vasculature, heart and gastrointestinal tract) (Stenzel et al., 1995; Burford et al., 2017). Various 
stimuli regulate CRH production and secretion, such as fear or anxiety, fluctuations in blood 
pressure and pain. Emotions influence CRH secretion as a result of neural connections between 
the paraventricular nucleus and limbic system. Other regulatory factors include catecholamines, 
acetylcholine, serotonin and inflammatory interleukins (ILs) (Deussing and Chen, 2018). Studies 
on mice deficient in both CRH receptors demonstrate immune, reproductive- and cardiovascular-
modulatory effects (Jeong et al., 1999). Direct effects of CRH on the cardiovascular system 
include elevated heart rate, increased cardiac output as well as elevated mean arterial pressure 
via the induction of NE and epinephrine (E) release (Deussing and Chen, 2018). 
Proopiomelanocortin is the precursor for ACTH and is synthesized in multiple brain sites, such as 
the arcuate nucleus of the hypothalamus, the LC and the pituitary gland. Proopiomelanocortin is 
cleaved in the anterior pituitary gland to produce ACTH (39 amino-acid peptide) and β-endorphin 
(92 amino-acid fragment) (Harno et al., 2018). Systemic circulation transports ACTH to the 
adrenal gland where it exerts a trophic effect as well as promoting the production and secretion 
of glucocorticoids, aldosterone and adrenal androgens (Figure 1) (Miller and Auchus, 2011). This 
means that regular exposure of adrenal tissue to fixed doses of ACTH, induces adrenal cortex 
hypertrophy and progressively increases the amount of glucocorticoids that are secreted – as 
evident in chronic stress (Bernatova et al., 2018). Furthermore, ACTH receptors are desensitized 
and downregulated when ACTH concentrations are high, and vice versa (McCarty, 2016). 
Although CRH is the most potent stimulator of ACTH secretion, other stimulants include arginine 
vasopressin, oxytocin, angiotensin II, serotonin, NE and E (Harno et al., 2018).  
Glucocorticoids play a key role in stress adaption by increasing the availability of biochemical 
resources as well as facilitating memory and learning (Table 2) (Myers et al., 2017). Due to the 
lipophilic nature of cortisol, its rate of secretion is controlled by regulation of its synthesis. Secreted 




circulating cortisol represents the active fraction which is in turn responsible for negative feedback 
inhibition on CRH and ACTH production (Johnson et al., 1992). Two types of glucocorticoid 
receptors exist and mediate this hormone’s effects. Type I receptors are predominantly found 
throughout structures that comprise the limbic system. Due to this system’s involvement in fear 
and anxiety, stimulation of such receptors alters behavioral responses to environmental and 
emotional stimuli, with subsequent changes in HPA axis activity (Burford et al., 2017). These 
receptors also display a high affinity for cortisol and are similar in structure to mineralocorticoid 
receptors. Type 2 glucocorticoid receptors are predominantly found in CRH neurons of the 
hypothalamus. Other important sites include the amygdala, hippocampus and nucleus tractus 
solitarius (Johnson et al., 1992), demonstrating that such receptors participate in behavioral, 
neuroendocrine and autonomic responses to stress.  
Glucocorticoids exert their effects by binding to specific receptors found in the cytoplasm of target 
cells. The hormone-receptor complex subsequently migrates to the nucleus, where it binds to the 
complementary hormone-response element found within the target DNA (deoxyribonucleic acid). 
This initiates the transcription of specific genes involved in metabolism, immune function, growth, 
inflammation and cognition (Oakley and Cidlowski, 2015). The primary metabolic outcome of 
glucocorticoids is the induction of hyperglycemia at the expense of protein and fat stores (Figure 
1). This is achieved by the upregulation of gluconeogenesis, glycogenolysis, protein degradation 
and lipolysis (Tsigos and Chrousos, 2002). Stress is often accompanied by tissue injury and an 
exaggerated inflammatory response. As this has the potential to cause harm, cortisol interferes 
with almost every step of the inflammatory pathway (Table 2). For example, glucocorticoids 
attenuate neutrophil phagocytosis, inhibit the production of inflammatory mediators and reduce 




Maladaptions in HPA axis activity following chronic stress exposure 
Evidence suggests that sustained hypo- or hyperactivation of the HPA axis is dependent upon 
the individuals’ age of exposure to and the duration of various stressors (van Bodegom et al., 
2017). However, most models of HPA axis dysregulation follow Selye’s General Adaptation 
Syndrome theory, suggesting that chronic stress elicits an eventual shift from a hyper- to a hypo-
responsive HPA axis (Selye, 1936). Initially, excessive hypothalamic and pituitary stimulation 
leads to increased glucocorticoid and decreased dehydroepiandrosterone production (Burford et 
al., 2017). Dehydroepiandrosterone is a glucocorticoid antagonist that is produced by the adrenal 
cortex and exerts beneficial effects, including the suppression of systemic inflammation and the 
attenuation of neurologic damage as a result of dysregulated cortisol secretion (Walker et al., 
2017). Although concurrent increases in glucocorticoid receptor (GR) sensitivity and expression 
occur, the number of GRs eventually subside. This leads to glucocorticoid resistance and 
impaired negative feedback inhibition of the HPA axis (Table 2) (Merkulov et al., 2017). Despite 
the inherent anti-inflammatory influence of glucocorticoids, this hormone also binds to 
mineralocorticoid receptors to subsequently induce a proinflammatory response (Hannibal and 
Bishop, 2014). Under normal conditions, this effect is prevented by enzymes that block the binding 
of cortisol with mineralocorticoid receptors. Reduced GR expression is further paralleled with 
adrenal cortex fatigue which in turn leads to hypocortisolism. This adaption is thought to be 
protective as it prevents chronic, glucocorticoid-induced immunosuppression and metabolic 
catalysis. Downregulation of CRH receptors further promotes hypocortisolism (Guilliams and 





Table 2: Effects of chronic stress-induced hyper- and hypocortisolism.  
Effects of hypercortisolism Effects of hypocortisolism 
Generalized immunosuppression (↓ leukocyte 
traffic and function, ↓ production of cytokines 
and blunted effects of inflammatory mediators 
on target tissue) (Burford et al., 2017). 
Immune activation (↑ production of 
proinflammatory cytokines, such as tumour 
necrosis factor-α, IL-6 and IL-12) and ↓ 
production of anti-inflammatory cytokines (IL-
4 and IL-10) (Elenkov and Chrousos, 1999). 
Inhibited reproductive axis (↓ gonadotropin-
releasing hormone) (Guilliams and Edwards, 
2010). 
Hypotension, hypoglycemia, weight loss and 
enhanced fatigability (Guilliams and Edwards, 
2010). 
Upregulated catabolism (↑ visceral fat 
deposition, ↓ lean body mass and ↓ osteoblast 
activity) (Siti et al., 2015). 
State of hypoarousal (Charmandari et al., 
2005). 
Inhibition of growth axis (↓ secretion of growth 
factors, such as growth hormone and insulin-
like growth factor-1, and ↑ somatostatin 







3.2.2 The SNS 
Acute response 
In 1929, Walter Cannon first described the activation of the LC-NE system following exposure to 
various stimuli (Cannon, 1929).  This system is largely contained within the brainstem and is 
highly integrated with and regulated by the hypothalamus, the cerebral cortex and the limbic 
system. Following activation, catecholamines are released into systemic circulation by 
sympathetic neurons and the adrenal medulla. These hormones induce various physiological 
adaptions, such as increased heart rate and cardiac output, simultaneous vasoconstriction and 
vasodilation as well as increased energy availability. Cognitive outcomes include a heightened 
sense of arousal and increased anxiety (Myers et al., 2017). 
Norepinephrine and E exert their effects via second messenger pathways and exhibit differing 
affinities for four distinctive adrenergic receptors, namely α1, α2, β1 and β2. Norepinephrine and 
adrenomedullary E bind to α1 and β1 receptors located near terminal sites of postganglionic 
sympathetic neurons (Kvetnansky et al., 2009). Thus, NE and E exert similar effects on target 
tissues, with E reinforcing SNS activity. However, E also possesses a high affinity for β2 receptors, 
which the SNS has little influence over. This is partially because β2 receptors are located in select 
tissues like skeletal muscle and bronchiolar smooth muscle. Epinephrine selectively promotes 
vasodilation of vessels supplying the heart and skeletal muscle, thereby increasing blood flow to 
these areas (Dyson et al., 2006; Golbidi et al., 2015). Arterioles in the digestive tract and the 
kidneys are only equipped with α1 receptors and therefore undergo more profound 
vasoconstriction during SNS activity (Charmandari et al., 2005).  
Maladaptions in SNS activity following chronic stress exposure 
Chronically stressed animals typically present with a hypersensitive SNS. This leads to 
hypertrophy and hyperplasia of adrenal tissue, with the concurrent upregulation of enzymes 




stressors leads to a reduced sympathomedullary response. Contrastingly, novel stressors induce 
exaggerated catecholamine release from the adrenal medulla (Groeschel and Braam, 2011; 
Golbidi et al., 2015). Autonomic-induced sustained upregulation of the renin-angiotensin-
aldosterone system (RAAS) system further leads to hypertension, vascular damage as well as a 
proinflammatory and prooxidative milieu (Häfner et al., 2012).  
Thus, the integrated stress response is highly complex and employs a wide variety of effectors to 
restore homeostasis by mobilizing biochemical resources and upregulating host defense 
mechanisms. However, most modern-day stressors present in the form of chronic existential, 
financial, family or personal worries. Such stressors lead to the sustained upregulation of the 
stress mechanisms which eventually result in alterations of physiological set-points as well as the 
“wear-and-tear” of various systems and structures. Although this may manifest in a multitude of 
different ways, the vasculature emerges as a crucial target as it is susceptible to excessive 
systemic levels of catecholamines and glucocorticoids.  
The next section highlights and explains the deleterious effects of stress hormones on the 





4. Chronic stress and endothelial dysfunction: proposed mechanisms 
Endothelial cells line the inner wall of all vasculature and play an essential role in maintaining 
vascular homeostasis (Incalza et al., 2018). The endothelium releases factors (e.g. paracrines) in 
response to chemical or physical challenges which function to locally regulate arteriolar calibre. 
For example, endothelial nitric oxide synthase (eNOS) produces nitric oxide (NO) which induces 
vasodilation by increasing cyclic guanosine monophosphate levels in smooth muscle cells 
(Fleming and Busse, 2003; Searles, 2006). A large body of evidence demonstrates that 
endothelial dysfunction plays a critical role in the pathogenesis of stress-mediated atherosclerosis 
and CVD (Lind et al., 2002; Spieker et al., 2002; Golbidi et al., 2015). This is characterized by 
endothelial activation, the release of adhesion molecules, impaired vascular reactivity as well as 
a proinflammatory, prooxidative and prothrombotic state (Figure 2) (Higashi et al., 2014).   
 
Figure 2: Potential mechanisms of chronic stress-induced endothelial dysfunction. HPA – 




1 – endothelin-1; NF-κB – nuclear factor kappa-light-chain-enhancer of activated B cells; VCAM-
1 - vascular cell adhesion molecule-1; ICAM-1 – intercellular adhesion molecule-1; eNOS – 
endothelial nitric oxide synthase; LC-NE – locus coeruleus-norepinephrine; ROS – reactive 
oxygen species; oxLDL – oxidized LDL; RAAS – renin-angiotensin-aldosterone system; ANGII – 
angiotensin II; NOX – NADPH oxidase.  
Atherosclerosis is the primary underlying pathology of CVD, with chronic stress also identified as 
a key driver of atherogenesis (Yao et al., 2019). This condition is characterized by the formation 
of atherosclerotic plaques in the walls of medium- to large-sized arteries (Ross, 1993; Bäck et al., 
2019). These lesions ensue following retention and oxidation of low-density lipoproteins (LDL), 
that is exacerbated by the presence of a chronic, low-grade inflammatory state. Maintaining 
endothelial integrity is crucial for preventing plaque development as lesions first occur in sites of 
dysfunctional and denuded endothelium (Mudau et al., 2012). Cholesterol is packaged in LDL 
which in turn infiltrates the vascular subendothelial space through defective and leaky endothelial 
cells. Here proatherogenic lipoproteins are oxidized and subsequently become proinflammatory 
and cytotoxic. With the help of cytokines (IL-8) and chemokines (monocyte chemotactic protein-
1), monocytes migrate across the dysfunctional endothelial layer. Once within the intima, newly 
formed macrophages engulf lipoproteins and become foam cells. Such cells continue to 
phagocytose LDL molecules until they die either via apoptosis or necrosis. The accumulation of 
dead, lipid-rich macrophages within the intima eventually results in the formation of a plaque, 
characterized by a destabilizing core and a fibrous cap (Falk, 2006). Inflammatory and 
hemodynamic forces degrade the cap and expose prothrombotic content into the blood. This 
triggers the clotting cascade, leading to vessel occlusion, myocardial infarction and stroke 
(Kasikara et al., 2018; Bäck et al., 2019). 
The following sections discuss the role glucocorticoids and catecholamines play in driving 




4.1 Glucocorticoids and endothelial dysfunction 
A large body of evidence supports a role for glucocorticoid-mediated endothelial dysfunction. 
Sustained circulating cortisol levels may lead to a variety of downstream vasculopathies by a) 
reducing endothelial NO synthesis, b) decreasing cyclic-adenosine monophosphate (cAMP) 
levels, c) interacting with GRs and d) promoting the secretion of endothelin-1 (ET-1) (Figure 2) 
(Nickel et al., 2009; Yammine et al., 2014; Golbidi et al., 2015).  
Reduced NO bioavailability is one of the hallmark features of endothelial dysfunction and is 
associated with atherosclerotic plaque development, as well as a proinflammatory and 
prothombotic state (Bonetti et al., 2003; Kalanuria et al., 2012). Endothelial NOS depends on the 
catalytic capabilities of five cofactors to effectively synthesize NO, i.e. flavin mononucleotide, 
flavin adenine dinucleotide, tetrahydrobiopterin, heme and calcium/calmodulin (Endemann, 
2004). If any cofactors are absent, or if there is limited availability of the substrate L-arginine, 
eNOS produces superoxide (SO) instead of NO. Superoxide is a potent free radical and its 
deleterious effects will be discussed in more detail later (Malekmohammad et al., 2019). 
Glucocorticoids directly reduce NO availability by inhibiting eNOS activity and expression (Figure 
2) (Liu et al., 2009; Toda and Nakanishi-Toda, 2011). In support, a study investigating the effects 
of cortisol on human umbilical endothelial cells showed that it lowered NO synthesis by 60% while 
GR antagonists ameliorated this effect (Wallerath et al., 1999).  
Adequate cAMP is crucial for intracellular signal transduction as well as the production and 
maintenance of endothelial cells (Fukuhra et al., 2006). Cyclic AMP also exerts important anti-
inflammatory properties via its actions on nuclear factor kappa-light-enhancer of activated B cells 
(NF-κB) kinase and tumour necrosis factor-α (TNF- α) (Golbidi et al., 2015). Elevated endothelial 
cAMP can reduce hyperglycemia-induced oxidative stress by attenuating reactive oxygen species 




suffering from poor mental health and CVD. An inverse relationship between oxidized LDL, 
atherosclerotic plaque development and cAMP also exists (Fantidis, 2010).  
Glucocorticoid receptors directly influence endothelial cells by modulating the expression of 
proinflammatory cytokines and chemokines (IL-6, IL-8 and monocyte chemotactic protein-1), 
cellular adhesion molecules (ICAM-1, vascular cell adhesion molecule-1 and E-selectin), 
vasodilators (NO) and vasoconstrictors (angiotensin II and ET-1) which are all crucially involved 
in preserving endothelial integrity and function (Zielińska et al., 2016; Burford et al., 2017). These 
receptors also influence blood pressure by sensitizing catecholamines and other vasoactivators. 
Additionally, GR-specific knockout mice display increased eNOS and inducible NOS expression 
(Liu et al., 2009).   
Recent studies implicated ET-1 as an important mediator of CVD development following chronic 
upregulation of the acute stress response (Yammine et al., 2014). ET-1 binds with the endothelin-
A receptor and contributes to the hypertensive response following chronic stress exposure (Fox 
et al., 2018). Both experimental and population-based studies demonstrated increased ET-1 
levels following psychosocial stress exposure in healthy and diseased subjects (Hong et al., 2006; 
Fernandez et al., 2010; Wilbert-Lampen et al., 2010; Burg et al., 2011; Fox et al., 2018).  
4.2 Catecholamines and endothelial dysfunction 
A surge of catecholamines are released following upregulation of the SNS. Norepinephrine and 
E negatively impact the endothelium by a) directly binding to adrenergic receptors, b) upregulating 
the RAAS and c) eliciting a prothrombotic state (Figure 2).  
Evidence supporting the direct effects of catecholamines on endothelial function is controversial. 
These hormones exert pressor effects on vasculature which directly oppose that of endothelial-
derived NO (Golbidi et al., 2015). Some showed that the administration of exogenous NE 




effects of β-receptor antagonists by preventing endothelial dysfunction and atherosclerotic plaque 
development (Boyle et al., 2005). Similarly, α-blockers attenuate SNS-induced reductions in FMD. 
However, experimental infusions of NE failed to replicate reductions in FMD as observed in 
human subjects following exposure to mental stressors (Spieker et al., 2002).  Acute stress can 
also promote eNOS activity (Seta et al., 2001). Conflicting findings may be a consequence of 
differing experimental protocols used for the upregulation of the SNS in human subjects. An 
important study in this regard investigated the four primary methods of SNS stimulation (cold 
pressor test, lower body suction, activation of the muscle chemoreflex and the mental arithmetic 
task) and found that reductions in FMD were not common amongst all tests (Dyson et al., 2006). 
Thus, it seems more likely that the indirect effects of catecholamines are responsible for inducing 
endothelial dysfunction. 
Chronically stressed and depressed individuals present with a perpetually upregulated RAAS 
(Figure 2) (Groeschel and Braam, 2011; Häfner et al., 2012). β-blockers such as propranolol can 
prevent increased RAAS activity (Clamage et al., 1976), while symptoms of anhedonia are 
ameliorated following the administration of angiotensin-converting enzyme inhibitors (Martin et 
al., 1990; Okuyama et al., 1999). Angiotensin II (ANGII) is a potent vasoconstrictor and a primary 
effector of the RAAS. Furthermore, this hormone facilitates atherogenesis by promoting lipid 
peroxidation (Keidar et al., 1995), hindering cholesterol efflux out of macrophages (Kaplan et al., 
2002) and stimulating the uptake of oxidized LDL by macrophages (Keidar et al., 2001).  
The binding of ANGII to type-1 receptors enhances the translocation and adhesion of leukocytes 
(Mateo et al., 2006, 2007) and augments the secretion of proinflammatory cytokines by 
endothelial and vascular smooth muscle cells (Liu et al., 2006; Chan and Leung, 2007). 
Candesartan is an angiotensin receptor antagonist that can confer cardiovascular benefits as well 
as improve HPA axis and SNS-associated responses to psychological stress (Pavel et al., 2008). 




development in apolipoprotein E-deficient mice (Wassmann et al., 2004) and reduces the number 
of macrophages found in plaques (Fukuda et al., 2008). Studies on ANGII type-2 receptors 
indicate that they may provide cardioprotective benefits by downregulating SNS activity (Grobe 
et al., 2007; Lima et al., 2013).  
4.3 Inflammation, oxidative stress and endothelial dysfunction 
Experimental studies report that chronically stressed humans and animals consistently present 
with a sustained, low-grade inflammatory and prooxidative state (Howren et al., 2009; Dowlati et 
al., 2010; Hiles et al., 2012; Siti et al., 2015) This state is characterized by an increased expression 
of proinflammatory mediators such as IL-6, IL-1β, C-reactive protein and TNF-α. In fact, evidence 
suggests bidirectional feedback between inflammation and depression as poor adherence to 
regular levels of physical activity or anti-inflammatory medications reversibly facilitates depression 
onset (Cohen et al., 2015). Inappropriate immune activation and excess ROS play a considerable 
role in propagating endothelial dysfunction (Figure 2). Inflammatory mediators may induce 
vascular pathology by a) decreasing the expression of eNOS mRNA (messenger ribonucleic acid) 
(Zhang et al., 1997), b) modulating calcium channel activity and expression (Tiwari et al., 2006), 
c) increasing ROS expression (Davignon, 2004) and d) enhancing cyclooxygenase expression 
(Mitchell et al., 1995).  
Immune reactions lead to the production of oxygen radicals as they play a crucial role in repair 
and defense mechanisms. In a similar way, ROS attracts immune cells and further exacerbates 
inflammatory reactions (Tang et al., 2015). Oxidative stress activates the NF-κB pathway which 
mediates inflammatory responses, regulates DNA transcription, activates the endothelium and 
influences cell growth (Baldwin Jr, 1996; Barnes and Karin, 1997).  It was proposed that NF-κB 
may be the link between chronic stress- and oxidative stress-induced organ dysfunction and 
impaired vascular regulation (Bierhaus et al., 2004). Inactive NF-κB is primarily found in the 




phosphorylation and degradation of IκB. The now liberated NF-κB migrates to the nucleus where 
it promotes proinflammatory cytokine expression, such as ILs, TNF-α, lipoxygenase, 
cyclooxygenase-2, adhesion molecules and inducible NOS (Golbidi et al., 2015). Furthermore, 
the anti-inflammatory effects of glucocorticoids on the endothelium are mediated by GR 
repression of NF-κB (Goodwin et al., 2013).  
 
Figure 3: The important role of SO and SOD in the vasculature. NADPH oxidase (NOX), 
xanthine oxidase, uncoupled eNOS and the mitochondrion are all important sources of SO (O2-) 
in the vascular wall. SO can react with nitric oxide (NO) to form toxic peroxynitrite (ONOO-). SOD 
is responsible for converting SO into hydrogen peroxide (H2O2). H2O2 can then spontaneously 
form a hydroxyl radical (OH) or be converted into H2O and oxygen (O2) by catalase or glutathione 




Oxygen radicals aid in host defense mechanisms, facilitate bacterial destruction and act as 
second messengers to help orchestrate intracellular signals (Incalza et al., 2018). Oxidative stress 
occurs when the production of ROS exceeds the buffering capabilities of antioxidants defenses 
(Figure 3) (Malekmohammad et al., 2019). There are many sources of ROS in the vasculature, 
including nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, perturbed eNOS 
functionality, mitochondrial enzymes and xanthine oxidase (Figure 3). Contrastingly, antioxidant 
defenses counteracting the excess ROS include superoxide dismutase (SOD), glutathione 
peroxidase and catalase (Figure 3) (Higashi et al., 2014; Santilli et al., 2015).  
Oxidative stress is thought to contribute to cardiovascular pathologies and augment 
atherosclerotic plaque development by inducing endothelial dysfunction, promoting lipid 
peroxidation, inflammation and insulin resistance (Pennathur and Heinecke, 2007; Santilli et al., 
2015). Cortisol promotes ROS formation via its effects on NADPH oxidase (NOX) and SOD. 
Furthermore, ROS activate the phosphoinositide 3-kinase pathway which ultimately results in the 
inhibition of eNOS expression and activity and further reductions in NO synthesis (Virdis et al., 
2013; Higashi et al., 2014; Incalza et al., 2018). 
Nicotinamide adenine dinucleotide phosphate oxidases are a family of prooxidative enzymes that 
are characterized by a membrane-bound subunit (Virdis et al., 2013; Santilli et al., 2015; Liao et 
al., 2018).  Angiotensin II is a key activator of NOX (Higashi et al., 2014), with the latter localized 
in vessel walls and a key source of SO production (Santilli et al., 2015). Other sources of SO 
include the mitochondrial electron transport chain, uncoupled eNOS and xanthine oxidase (Figure 
3). Superoxide can contribute to the formation of other ROS such as the hydroxyl radical, 
hydrogen peroxide and peroxynitrite (Incalza et al., 2018). High ROS levels lead to the oxidation 
of the eNOS cofactor, tetrahydrobiopterin and results in the uncoupling of eNOS which further 
promotes SO instead of NO production. Tetrahydrobiopterin was subsequently identified as an 




(Malekmohammad et al., 2019). Additionally, SO combines with NO to form toxic peroxynitrite 
which facilitates protein nitration and endothelial cell death (Figure 3) (Siti et al., 2015).  
5. Conclusion 
Chronic stress is not only a key element of psychiatric disorders, but in recent years emerged as 
an underestimated risk factor and potentiator of CVDs. The associative link between chronic 
stress and CVD was firmly established by a variety of large-scale epidemiological studies 
(Rosengren et al., 2004; O’Donnell et al., 2016; Sgoifo et al., 2017). Although the underlying 
molecular mechanisms driving CVD onset are largely unknown, experimental research 
demonstrates that the upregulation of the HPA axis and SNS are of paramount importance 
(Johnson et al., 1992; Chrousos, 2009). Glucocorticoids and catecholamines represent the 
primary effectors of such systems and exert a vast array of downstream cardiac, metabolic and 
behavioral effects. A healthy endothelial layer is crucial for maintaining cardiovascular and 
hematological homeostasis. However, this single layer of cells is susceptible to the deleterious 
effects of excessive, systemic glucocorticoid and catecholamine levels. These hormones may 
directly decrease NO synthesis, perpetually upregulate the RAAS and promote the secretion of 
potent vasoconstrictors. Furthermore, they can indirectly facilitate endothelial damage and 
dysfunction by encouraging a proinflammatory, prooxidative and prothrombotic milieu (Figure 2) 
(Golbidi et al., 2015; Incalza et al., 2018; Yao et al., 2019; Yousaf et al., 2019). Inflammatory 
mediators and toxic free radicals further exacerbate this response and augment eNOS 
uncoupling, lipid peroxidation and ultimately promote atherogenesis (Figure 2). Should this 
dysfunction go untreated, it may lead to impaired vascular compliance, the development of 
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Chapter 2:                                    
Two Months of Unpredictable 
Chronic Mild Stress Impairs 






Chronic stress plays an increasingly integral part of modern-day living. Evidence suggests that 
inadequate stress-coping mechanisms facilitate the development of cardiovascular disease. 
Endothelial dysfunction is characterized by the reduced bioavailability of nitric oxide and 
represents an important step in disease progression. To investigate whether non-habituating 
stress impairs endothelial function, we subjected male Wistar rats (weighing 200 – 250 g) to eight 
weeks of unpredictable chronic mild stress (UCMS). After euthanasia, we measured plasma 
concentrations of stress-hormones, assessed aortic vascular reactivity to vasodilators and 
vasoconstrictors as well as investigated the activity of antioxidant enzymes. Eight weeks of UCMS 
had no effect on circulating corticosterone or epinephrine levels, however plasma 
adrenocorticotropic hormone was significantly reduced. We noted blunted acetylcholine-induced 
vasorelaxation with no differences in phenylephrine-induced vasoconstriction. Additionally, we 
observed reduced vascular superoxide dismutase activity. Collectively, our data supports a role 
for chronic stress-induced impairments in endothelial-dependent dilation. This may due to 
increased oxidative stress levels, uncoupled endothelial nitric oxide synthase and reduced nitric 
oxide availability.    





Chroniese stres speel toenemend ’n integrale rol in die hedendaagse lewe. Bewyse dui daarop 
dat onvoldoende meganismes vir streshantering die ontwikkeling van kardiovaskulêre siektes 
bevorder. Endoteel wanfunksie word deur die verminderde biobeskikbaarheid van stikstofoksied 
gekenmerk en is 'n aanduidende stap in die progressie van siektes. Om te ondersoek of nie-
gewoontevormende stres ten einde die endotheelfunksie belemmer, het ons manlike Wistar-rotte 
(wat 200 - 250 g weeg) aan onvoorspelbare chroniese ligte spanning (UCMS) vir ’n tydperk van 
agt weke onderwerp. Na genadedood het ons plasmakonsentrasies van streshormone gemeet 
asook die aorta-vaskulêre reaktiwiteit teenoor vasodilators en vasokonstriktore beoordeel en die 
werking van antioksidantensieme ondersoek. Agt weke UCMS het geen effek op die sirkulerende 
kortikosteroon- of epinefrienvlakke getoon nie. Die adrenokortikotropiese hormoon van plasma 
was wel aansienlik verlaag. Ons het kennis geneem van afstomping van asetielcholien-
geïnduseerde vaso-ontspanning sonder verskille in fenielefrien-geïnduseerde vasokonstriksie. 
Verder het ons 'n verminderde vaskulêre superoksied-dismutase-aktiwiteit waargeneem 
Gesamentlik ondersteun ons data 'n rol vir chroniese stres-geïnduseerde inkortings in endotheel-
afhanklike dilatasie. Dit kan wees as gevolg van verhoogde oksidatiewe stresvlakke, 






As the developing world continues to expand, stress plays an increasingly central role in the 
modern-day way of life. Although transient stress exposure is essential for healthy growth and 
development, evidence shows that unremitting psychosocial stress precipitates poor mental 
health and increases an individual’s susceptibility to various morbidities (McEwen, 1998; 
Chrousos, 2009). Of note, recent evidence demonstrates a strong associative link between 
chronic stress and CVD (Rosengren et al., 2004; O’Donnell et al., 2016; Esler, 2017).  
The most prevalent modern-day stressors are job strain, social isolation and personal or family 
burdens (Nyberg et al., 2013; Non et al., 2014; Wilson et al., 2014). As these stressors are non-
physical, our body’s inherent stress response is largely rendered inappropriate. Despite the 
remarkable ability of animals to adapt and habituate to challenging stimuli, research indicates that 
perpetual psychosocial stressors chronically upregulate stress-response mechanisms. This leads 
to disrupted endocrine and autonomic function which in turn advances behavioral and 
cardiovascular derangements (Agorastos et al., 2018).  
Chronically stressed individuals typically present with elevated circulating levels of glucocorticoids 
and catecholamines. These effectors exert profound cardiovascular, metabolic and immunologic 
affects (Charmandari et al., 2005). Given the proximity of these hormonal factors to the 
endothelium as well as the sensitivity of endothelial cells to hematologic and inflammatory 
alterations, it is not surprising that this single-cell layer has emerged as a particularly susceptible 
target of perturbed neuroendocrine function (Golbidi et al., 2015). Furthermore, endothelial 
dysfunction, which is characterized by reduced NO levels, represents an important step in the 
pathogenesis of atherosclerosis amongst other vascular aberrations (Yao et al., 2019).  
The use of appropriate animal models is crucial for investigating linking mechanisms between 
chronic stress and vascular disease (Neumann et al., 2011; Scharf and Schmidt, 2012). The 




depressive-like behaviors in rodents. The reproducible capacity of this model to elicit behavioral 
and neuroendocrine symptoms similar to those of depressed individuals is testament to its validity 
and reliability (Frisbee et al., 2015; Antoniuk et al., 2019).  
Although the behavioural alterations induced by the UCMS model are well established, few 
studies have employed this model to interrogate the link between chronic stress and endothelial 
dysfunction. In light of this, we subjected male Wistar rats to 8 weeks of UCMS to test our 
hypothesis that non-habituating stressors would impair endothelial function as a result of a 
dysregulated HPA axis and SNS. We further hypothesize that attenuated endothelium-dependent 
dilation would be accompanied by increased oxidative stress.  
1.1 Hypothesis, aims and objectives summary 
We hypothesize that eight weeks of UCMS would lead to 1) dysregulated HPA axis and SNS, 2) 
impaired endothelial function and 3) increased oxidative stress. 
Aims: 
1. Identify perturbations in HPA axis and SNS activity. 
2. Determine whether endothelium-dependent vascular reactivity is impaired. 
3. Measure vascular oxidative stress levels. 
Objectives: 
1. Assess the plasma concentration of various stress hormones: ACTH, corticosterone, 
epinephrine. 
2. Measure the endothelial-dependent response to vasoconstrictors and vasodilators. 
3. Investigate the plasma concentration of ET-1, a systemic marker of endothelial damage. 





2. Methods and materials 
2.1 UCMS protocol and experimental design 
The Unpredictable Chronic Mild Stress (UCMS) model was established as a translationally-
relevant protocol for inducing physiological, neurobiological and behavioural symptoms that are 
clinically associated with chronic stress and depression (Frisbee et al., 2015; Antoniuk et al., 
2019). This section details our adaption of the UCMS model.  
The aim of this study was to investigate the effects of chronic stress on the cardiovascular system, 
with emphasis placed on assessing endothelial integrity and functionality. Two distinct 
experimental runs of the UCMS protocol were conducted. The aim of the first experiment (joint 
research work completed by Lucien Sher and Lukas Olivier) was an attempt to establish the 
UCMS in our laboratory and successfully induce a phenotype of chronic stress in male Wistar 
rats. Following various oxidative stress tests and molecular analyses, we were unable to confirm 
the successful implementation of the model, as no significant differences were observed between 
groups (refer Supplementary Data). We subsequently adapted the protocol to ensure the 
successful establishment of the model with a second experimental run. Although both protocols 
were executed in the same animal laboratory, the duration of some stressors was increased and 
now conducted during the sleep phase (versus awake phase for first run). While the experimental 
procedure of each protocol is described in detail below, the results of the second experiment will 
be the focus of this study.  
At the end of the second UCMS protocol, endothelial functional assessments were performed on 
harvested rat aortas and additional molecular analyses included: a) measuring the plasma 
concentration of various stress-linked hormones, b) assessing the degree of SOD and NOX 
activity and c) probing for markers of endothelial damage. Collectively we aimed to gain a better 
understanding of how the chronic upregulation of the HPA axis and the SNS may contribute to 




for CVD onset, the current investigation should provide foundations for future molecular 
mechanisms to be explored.  
2.1.1 Animals and ethics statement 
The animals in this study were treated in accordance with the Guidelines for the Care and Use of 
Laboratory Animals of the National Academy of Science (National Institute of Health publication 
No. 85-23, revised 1996). This study was performed with the approval of the Animal Ethics 
Committee of Stellenbosch University, (Ethics #: ACU‐2018‐6311) (Appendix A).  
2.2 Experimental procedures 
First experimental run: For this experiment, 18 male Wister rats were obtained (200-250 g) 
and randomly divided into two groups, namely: Control and Stress (n = 9 per group). All rats were 
housed one-per-cage and in the same room for the duration of the entire protocol. Both groups 
experienced a 12-hour day-night cycle and had ad libitum access to standard chow and water. 
The rats were afforded one week to acclimatize to the investigators and their surrounding 
environment. Following the acclimatization period, the UCMS protocol was initiated (Figure 4). 
The Control group was largely left alone and did not experience any stressors (as detailed for the 
UCMS protocol) for the duration of the study (eight weeks). By contrast, the Stress group was 
exposed to one stressor per day, lasting either four or eight hours (depending on the stressor), 
for six days per week. Such stressors were applied during the awake phase and were chosen in 
a random fashion to minimize habituation (Table 3). Rats were stressed during the awake phase 
to better simulate the human context. Body weight and food consumption were measured on the 





Figure 4: Schematic representation of the experimental procedure. 
Second experimental run: For this experimental procedure, 32 male Wistar rats (200-250 g) 
were randomly divided into three groups: Control (n = 12), Stress (n = 12) and Negative Control 
(n = 8). Unlike the first experimental run, the Control and Stress groups were now housed in 
separate rooms. Moreover, the Control group was housed two-per-cage and rats of the Stress 
group were housed individually. Control rats were housed in separate rooms to prevent the 
possibility of any communication between groups. Because rats are social animals, individual 
housing is a stressor in itself and for this reason the Control rats were now housed in pairs 
(Antoniuk et al., 2019).  Rats in the Negative Control group were housed four-per-cage in a third 
room. Following the acclimatization period, the Stress rat group was exposed to one random 
stressor per day, for a period of four to eight hours (depending on the stressor).  Notably, such 
stressors were now applied during the sleep phase as indicated in the original UCMS protocol 
(Frisbee et al., 2015). To increase stressor severity, the duration of the Damp Bedding and Cage 
Tilt stressors were extended to eight hours. For the same reason, cat litter was replaced with 





Table 3: Description of the UCMS stressors for each of the respective experimental 
procedures.   
Stressor 
Experimental Procedure 1 
(Rats stressed during awake phase) 
Experimental Procedure 2 
(Rats stressed during sleep phase) 
Damp 
Bedding 
Approximately 500 mL of water was 
added to the rat’s bedding in such a 
way to avoid its pooling within the cage 
(4 hours).  
Stressor was not altered; however, 
duration increased to 8 hours. 
No 
Bedding 
The rat’s bedding was removed from 
the cage for the duration of this 
stressor (4 hours).  
Stressor was not altered. 
Cage Tilt 
This rat’s cage was tilted at an angle of 
45° and the bedding was removed for 
the entirety of this stressor (4 hours).   
Stressor was not altered; however, 
duration increased to 8 hours. 
Light/Dark 
This stressor involves the disruption of 
the rat’s light-dark cycle. During the 
awake phase, the lights were turned on 
and off, every 30 minutes, for a period 
of 8 hours.   
Lights were turned on and off, every 
30 minutes, for a period of 8 hours 





The rats were exposed to cat litter that 
had been urinated on by a common 
house-cat (4 hours). 
The rats were exposed to 
concentrated bobcat urine (liquid and 
granulated form) (4 hours). 
Social 
Stress 
All Stress rats had to spend the 
duration of this stressor in a 
neighboring rat’s cage (4 hours). 
Stressor not altered.   
 
2.2.1 Weight and food consumption 
The weight of the provided standard chow was determined before placement into cages. On the 
seventh day of each week, the remaining pellets were removed, weighed and the difference 
between the two pellet weights indicated the amount of food consumed per cage. The average 
weekly food consumption was then extrapolated from this data. This was carried out for the 
duration of the study.  
2.2.2 Blood and tissue collection 
Rats were anesthetized using 5% isoflourane gas (Piramal, Bethlehem PA) a week prior to the 
end of the second experimental run. Approximately 1.5 mL of blood was drawn from the right or 
left common carotid artery and immediately transferred into ethylenediaminetetraacetic acid 
(EDTA) vacutainers (BD, Franklin Lakes NJ). Subsequent to the rats being placed on their back, 
a hypodermic needle was inserted in the space between the sternum forelimb to pierce the carotid 
artery. Within 30 minutes of collection, blood was centrifuged at 1, 000 x g for 15 minutes at 4°C 
(Boeco M240, Hamburg, Germany). The supernatant was then transferred into fresh microfuge 




At the end of the second experimental run, rats were euthanized with an intraperitoneally 
administered overdose of sodium pentobarbital (Piramal, Bethlehem PA). Following excision of 
the heart, blood was collected in EDTA vacutainers (BD, Franklin Lakes NJ) and centrifuged at 1, 
000 x g for 15 minutes at 4°C (Boeco M240, Hamburg, Germany). The supernatant was then 
transferred into fresh microfuge tubes and stored at -80°C for later analysis.  Following blood 
collection, the aorta was immediately dissected and transferred to ice-cold Krebs-Henseleit (KH) 
buffer (NaCl 119 mM, NaHCO3 24.9 mM, KCl 4.7 mM, KH2PO4 1.2 mM, MgSO47H2O 0.59 mM, 
Na2SO4 0.59 mM, CaCl2H2O 1.25 mM and glucose 10 mM). Together with plasma, the remaining 
organs were harvested and stored at -80°C for further molecular analyses.  
2.3 Analyses 
A variety of analyses were performed on aortic tissue and plasma to identify differences in HPA 
axis and SNS activity and perturbations in endothelial function. These included enzyme-linked 
immunosorbent assays (ELISAs), vascular function analyses and oxidative stress tests.  
2.3.1 ELISAs 
ELISAs were obtained (Elabscience Biotechnology Inc, Houston TX) for the determination of 
plasma ACTH (E-EL-R0048), corticosterone (E-EL-R0269), E (E-EL-0045) and ET-1 (E-EL-
R1458) concentrations (Appendix B). Here, the ACTH and corticosterone assays were both 
performed on blood drawn from the carotid artery whereas the E and ET-1 ELISAs were 
conducted on blood drawn following excision of heart.  
The standard working solution, biotinylated detection antibody and sample were incubated for 45 
minutes at 37°C in a 96-well plate that had been pre-coated with either rat ACTH, corticosterone, 
E or ET-1 antibodies (Ab). During the reaction, the hormone to be measured in the sample, 
competes with a fixed number of hormone-specific sites on the biotinylated detection Ab. Excess 
unbound sample or standard was washed from the wells before horseradish peroxidase (HRP) 




the HRP enzyme was then added before the reaction was terminated by the stop solution. The 
color change was measured spectrophotometrically at a wavelength of 450 nm (EZ Read 400 
Microplate reader, Biochrom, Holliston MA). Hormone concentrations were then extrapolated 
from these data (Appendix B).  
2.3.2 Vascular function analyses 
All reagents were prepared each day according to standard protocols (Appendix C). Following 
euthanasia, harvested aortas were immediately arrested in ice-cold KH buffer (Appendix C). 
Excess connective and adipose tissue were then carefully removed from the exterior vessel wall 
before the aortic ring (3 mm) was mounted on the rig (Biopac Systems Inc., Goleta CA). The aortic 
ring was then lowered into KH buffer (NaCl: 119 mM, NaHCO3: 24.9 mM, KCl: 4.7 mM, KH2PO4: 
1.2 mM, MgSO47H2O: 0.59 mM, Na2SO4: 0.59 mM, CaCl2H2O: 1.25 mM and glucose: 10 mM), 
maintained at approximately 36.5-37°C and gassed with 95% O2 and 5% CO2.  
Tension was gradually increased to from 0 to 1.5 g over a total period of 30 minutes, with buffer 
changes at 10 and 20 minutes respectively. Next, 2.5 μL of 1 mM phenylephrine (Phe) stock 
solution (Appendix C) was then added to 25 mL of KH buffer to induce aortic vasoconstriction. 
Once maximal contraction had been achieved, 25 μL of a 10 mM acetylcholine (ACh) stock 
solution (Stock A) was then administered to the water bath. Following maximal dilation, the aorta 
was washed 3 times with pre-warmed KH buffer and stabilized at 1.5 g for another 30 minutes, 
with washing steps at 10 and 20 minutes respectively. Cumulative concentrations of Phe followed 
by cumulative concentrations of ACh were then added (Mudau et al., 2012) (Table 4). 
Table 4: Cumulative doses of the respective drugs administered.  
1. Cumulative doses of Phe 2. Cumulative doses of ACh 




Add 5 μL of 1 mM stock solution. Add 17.5 μL of Stock C. 
Add 5 μL of 1 mM stock solution. Add 42.5 μL of Stock C. 
Add 7.5 μL of 1 mM stock solution. Add 14.3 μL of a 100 μM solution (Stock B) 
Add 5 μL of 1 mM stock solution. Add 220 μL of Stock B. 
 
The experiment was concluded once maximal vasodilation had been achieved.  Results were 
analyzed using AcqKowledge Software (Biopac Systems Inc., Goleta CA) and the remaining 
aortic tissue was stored at -80°C for later molecular analysis.  
2.3.3 Oxidative stress analyses 
Pulverised aortic tissue was combined with 500 μL of phosphate-buffered saline (PBS) (pH 7.4) 
in 2 mL microfuge tubes (Appendix D). The tissue was further homogenized by adding 7 stainless 
steel beads (1.6 mm) (Next Advance, Troy NY) to the tubes and, using a Bullet Blender (Next 
Advance, Troy NY) (speed setting of 8) for 5x one-minute periods, with a minute interval in 
between. The homogenate was then centrifuged (Boeco M240, Hamburg, Germany) for 20 
minutes at 4°C at 21, 950 x g. The supernatant was subsequently transferred into fresh microfuge 
tubes and stored at -80°C for later analyses.  
2.3.3.1 SOD assay 
To measure the concentration of SOD, 12 μL of sample was combined with 15 μL of 1,6-
hexanediol and 53 μL of SOD phosphate buffer in a clear 96-well plate (Appendix D). Next, 170 
μL of DETAPAC (Diethylenetriaminepentaacetic acid) was then added to initiate the reaction 
which was measured at a wavelength of 490 nm for five minutes (Multiskan Spectrum, Thermo 
Electron corporation, Waltham MA). Superoxide dismutase is known to inhibit the reaction 




reaction inhibition. The concentration of SOD was then determined using the generated 
absorbance readings (Appendix D).  
2.3.3.2 NADPH oxidase assay 
The degree of NOX activity was determined using a modified assay (Abid et al., 2007) (Appendix 
D). A luminometer was used to measure the degree of emitted light generated when NADPH 
oxidase complex donates electrons to lucigenin. An assay buffer containing 120 mM NACl, 250 
mM HEPES (pH 7.4), 5.9 mM KCl, 11 mM glucose, 1.75 mM CACl2(2H2O), 0.5 mM EDTA, 100 
μM NADH and 5 μM of lucigenin was combined with 100 μL of sample in a 96-well plate. Light 
emission was then detected over a period of 25 minutes with a Glomax-96 luminometer 
(Promega, Madison WI). Readings were then expressed as enzyme units (U)/mL (Appendix D).  
2.4 Statistical analysis 
All statistical analyses were performed using Statistica 13.0 (StatSoft Inc., Dell Software, Tulsa 
OK) and done in conjunction with Prof. Martin Kidd at the Centre for Statistical Consultation at 
Stellenbosch University. Body weight, percentage growth and food consumption data were 
analyzed with a repeated-measures analysis of variance (ANOVA) test. All normally distributed 
data comparing Control vs. Stress was evaluated using an unpaired t-test. Non-parametric data 
was analyzed using a Mann-Whitney test. A two-way ANOVA with Bonferroni post-hoc analysis 
was used to evaluate all endothelial functional data. Linear regression analyses were also 
performed on data generated from endothelial function assessments. A P-value <0.05 was 
considered significant and any outliers were excluded by means of a Grubbs test. All data is 
presented using Graphpad Prism 5.01 (Graphpad Software Inc, San Diego, CA) as mean ± 





Part of this study was completed in conjunction with another MSc student in our department 
(Lukas Olivier). Consequently, body weight (Figures 5 and 6) and food consumption (Figure 7) 
data were jointly generated by both investigators. Following completion of the UCMS protocol, 
blood from the first 6 rats of each group was designated to Lukas Olivier while the blood from the 
remaining 6 rats from each group was given to Lucien Sher for later analysis. Here, both 
investigators independently investigated the plasma concentration of various important stress 
hormones, namely: ACTH and corticosterone. Data sets generated from the ELISAs were 
reported both individually (Figure 8-9A) and in collaboration (Figure 8-9B) in order to increase 
sample size (from n = 6 to n = 12) and provide a more holistic depiction of the outcomes of the 
stress protocol. All other experiments were solely conducted by Lucien Sher (Figure 10 – 17). Of 
note, the Negative Control data was not included in any of the figures as we found no significant 
differences when compared to Controls.  
3.1 Body weight 
The body weight of each rat was recorded on a weekly basis (Figure 5) and expressed as a 
percentage of the rat’s baseline weight (Figure 6). Although rats from the Control and Stress 
groups were age-matched, the Control group weighed significantly more than the Stress group 
for the duration of the study – to be discussed later. Notably, the rate of weight gain for the Stress 
group was higher than the Control group throughout the experiment and differed by 23 ± 3% at 
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Figure 5: An assessment of body weights for Stress versus Control groups (data jointly 
generated in collaboration with Lukas Olivier). Data displayed as mean ± standard error of the 
mean (SEM); statistical analyses: repeated measures, two-way analysis of variance (ANOVA), 
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Figure 6: Percentage weight gain which was cumulative from the beginning of the study 
(data jointly generated in collaboration with Lukas Olivier). Data displayed as mean ± SEM; 
statistical analyses: repeated measures, two-way ANOVA, Bonferroni post hoc; *p<0.05, 
****p<0.0001; n = 12. 
3.2 Food consumption 
At the end of each week the remaining pellets were weighed, and the amount of consumed 
standard chow was determined (Figure 7). The Control group ate significantly more than the 
Stress group at the end of the first week (p<0.05), while the Stress group consumed more food 
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Figure 7: Food consumption for the Stress versus Control groups over the eight-week 
period (data jointly generated by Lucien Sher and Lukas Olivier). Data displayed as mean ± 
SEM; statistical analyses: repeated measures, two-way ANOVA, Bonferroni post hoc; *p<0.05, 
***p<0.001; n = 12. 
3.3 ELISAs 
3.3.1 ACTH 
Plasma ACTH levels were measured as marker of HPA axis activity and no differences were 
initially observed (Figure 8A).  However, the combined data revealed attenuated ACTH levels in 










































Figure 8: Plasma ACTH levels in response to stress. A - Data displayed as mean ± SEM; 
statistical analyses: unpaired t-test; Control and Stress: n = 6 (data generated by Lucien Sher). B 
– Data displayed as mean ± SEM; statistical analyses: unpaired t-test; *p<0.05; n = 12 (combined 





Plasma corticosterone levels were also determined as it is one of the primary stress hormones 
and a reliable marker of HPA axis activity.  No significant differences were initially observed 
(Figure 9A and 9B). To gain greater insights into these data, we also plotted the individual data 
points (refer black circles for Figure 9B).  Interestingly, it seems that there are two distinct patterns, 
i.e. hyper- and hypo-responsive subgroups in response to the chronic stress protocol (Figure 9B).  
Although this phenomenon was maintained for the combined data (Figure 9B), no subgroups 

































































Figure 9: Plasma corticosterone concentrations in response to chronic stress. A – Data 
displayed as mean ± SEM; statistical analyses: unpaired t-test; n = 6 (data generated by Lucien 
Sher). B – Data displayed as mean ± SEM; statistical analyses: unpaired t-test. Control: n = 12 





Plasma E concentrations were measured to gauge sympathomedullary activity. No significant 
differences in E levels were observed between groups (Figure 10).  























Figure 10: Plasma E concentrations in response to chronic stress. Data displayed as mean 






ET-1 is released from the endothelium in response to endothelial damage or dysfunction (Fox et 
al., 2018). No significant differences in plasma ET-1 expression were noted (Figure 11). 



















Figure 11: Plasma ET-1 levels in response to chronic stress. Data displayed as mean ± SEM; 
statistical analyses: unpaired t-test; n = 12 (data generated by Lucien Sher).   
3.4 Endothelial function 
Endothelial function was assessed by testing the contractile and dilatory ability of harvested aortic 
rings following exposure to Phe and ACh, respectively (Figure 12-16). Although no differences in 
the contractive ability of the aortic rings were noted (Figure 12 and 14), our results show that the 
dilatory ability of the Stress aortas was impaired when compared to Controls (p<0.05 and 




significantly more ACh than the Control (p<0.05) (Figure 15). Overall, aortic rings from the Control 
group relaxed more than the Stress group following administration of the last dose of ACh 
(p<0.05) (Figure 16B).  
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Figure 12: Harvested aortas exposed to cumulative doses of Phe to stimulate 
vasoconstriction. Data displayed as mean ± SEM; statistical analyses: repeated measures 2-
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Figure 13: Administration of varying ACh concentrations to induce vasodilation of aortic 
rings. Data displayed as mean ± SEM; statistical analyses: repeated measures 2-way ANOVA, 
Bonferroni post hoc; *p<0.05, **p<0.005. Control: n = 7 and Stress: n = 11 (data generated by 
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Figure 14: Nonlinear regression of Phe-induced vasoconstriction.  Data displayed as mean 
± SEM; statistical analyses: repeated measures 2-way ANOVA, Bonferroni post hoc; Control: n = 
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Figure 15: Nonlinear regression of ACh-induced vasodilation.  Data displayed as mean ± 
SEM; statistical analyses: repeated measures 2-way ANOVA, Bonferroni post hoc; *p<0.05; 










































Figure 16: The degree of vasoconstriction (A) and vasodilation (B) after the final dose of 
the respective drugs were administered. All data displayed as mean ± SEM; statistical 
analyses: unpaired t-test; *p<0.05; Control: n = 7 and Stress: n = 11 (data generated by Lucien 
Sher). 
3.5 Oxidative stress 
Oxidative stress is one of the key mechanisms by which endothelial damage and dysfunction may 




oxygen and hydrogen peroxide from the superoxide molecule. Our data revealed that SOD activity 
was lower in the Stress group versus Controls (p<0.05) (Figure 17A). The activity of NOX was 
assessed as this enzyme is a key producer of ROS however, no differences in NOX activity were 
observed (p = 0.13) (Figure 17B).  


























Figure 17: The activity of (A) SOD and (B) NOX in the thoracic aorta following chronic 





A large body of epidemiological and experimental evidence points towards a causative link 
between chronic psychosocial stress and the onset of CVD. However, limited knowledge exists 
regarding the molecular derangements that underpin the development of such cardiovascular 
pathologies. In light of this, we employed the UCMS model to further elucidate the underlying 
mechanisms whereby the sustained upregulation of stress-response systems may lead to 
compromised vascular function. In this study, two-months of UCMS resulted in 1) decreased 
plasma ACTH concentrations, 2) impaired endothelium-dependent dilation and 3) attenuated 
vascular SOD activity.  
4.1 Efficacy of the UCMS model  
The use of appropriate animal models is crucial for elucidating the negative effects of chronic 
stress on the cardiovascular system (Neumann et al., 2011). Ideally these models should mimic 
the human context as accurately as possible, highlight pathological mechanistic contributors, elicit 
reproducible behavioural and physiological outcomes as well as provide opportunity for 
therapeutic intervention (Willner, 1997; Farooq et al., 2012; Frisbee et al., 2015). In light of these 
criteria, the efficacy of the UCMS model was validated by a number of studies (Table 5: studies 
1-20).  This model recruits appropriate neuroendocrine systems to induce behavioural and 
physiological adaptations analogous to those of patients suffering from poor mental health 
(Antoniuk et al., 2019). Moreover, these symptoms are blunted following the administration of 
antidepressants, adrenergic receptor-blockers or natural remedies (Table 5: studies 1-2; 13-14; 
16-19).  
Behavioural adaptations and alterations in plasma or serological concentrations of stress 
hormones (corticosterone, ACTH, E) serve as the basis for confirming the successful 
implementation of the UCMS protocol (Frisbee et al., 2015). Tests used to describe and measure 




suppression test (Isingrini et al., 2011). The reward test functions as a measure of anhedonia by 
demonstrating that repeated exposure to unpredictable stressors suppresses the acquisition of 
an appetite behaviour that is induced and maintained by a highly palatable food (Gambarana et 
al., 2001). The splash test assesses standards of self-care and motivational behaviour by 
measuring the frequency and latency to initiate grooming after being sprayed by a 10% sucrose 
solution. Lastly, the novelty suppression test promotes a motivational conflict between eating 
behaviour and the fear of novelty. This is measured by the latency to initiate sniffing and eating 
of a food pellet (Ibarguen-Vargas et al., 2008; Isingrini et al., 2011).   
Although the UCMS model represents a reliable tool for studying stress-mediated pathology, a 
high degree of variability exists across experimental studies (Table 5). This presents in the form 
of stressor regimen, method of euthanasia as well as animal species, strain and housing. Despite 
studies exposing animals to mild stressors in a randomized fashion, the number, character, 
severity and duration of UCMS stressors often differ. The length of the UCMS protocol may also 
differ with studies employing a varied experimental duration of 2-8 weeks (Table 5). For example, 
some even exposed mice to two separate stints of UCMS with a 6-week break in-between 
(Isingrini et al., 2012). Animal housing is another important variable as rodents are social by 
nature. This means that individual housing is a stressor on its own. Contrastingly, housing two-
or-more rats per cage provides camaraderie which negates the pathological effects of UCMS 
(Frisbee et al., 2015).  
Although a variety of different animals have been subjected to the UCMS protocol, the most 
common species employed are mice and rats. Rodent strains of note include Balb/c mice as well 
as Wistar-Kyoto and Sprague-Dawley rats (Table 5). A number of studies also employed 
apolipoprotein E-deficient (ApoE-/-) mice to study the confounding effects of chronic stress on 
atherosclerotic plaque development (Table 5: studies 4-6). Species, strain and gender are 




and Wang, 2010). For example, Balb/c mice are largely susceptible to the broad effects of chronic 
stress (Mineur et al., 2006; D’Audiffret et al., 2010), however they have intriguingly demonstrated 
particular resilience to developing vascular dysfunction (Friedman et al., 2000; Miyoshi et al., 
2007). In line with this, d’Audiffret and colleagues noted variability in the pathological outcomes 
of vascular dysfunction in genetically identical mice subjects (D’Audiffret et al., 2010). This 
suggests that individual responses to chronic UCMS may be heterogenous, even within a 
genetically identical strain. Furthermore, variable adaptions to challenging stimuli may lead to 
diverse avenues through which pathophysiological outcomes can precipitate. 
Gender plays an equally important role, especially with regards to behavioural testing. For 
example, basal and stress-induced changes in sucrose consumption are differently expressed 
between male and female rats (Dalla et al., 2005, 2008; Pitychoutis et al., 2009). This may be a 
consequence of gender-orientated differences in taste (Clarke and Ossenkopp, 1998; Curtis et 
al., 2004) or in response to a reward (Michaels and Holtzman, 2007). Overall, males present with 
decreased preference to sucrose following UCMS however, females seem to be more susceptible 
to UCMS in the context of other behavioural and biochemical tests (Dalla et al., 2005, 2008). 
Thus the ability to accurately study the associated-negative effects of chronic stress on the body, 
is heavily dependent on the adequacy of the model used to induce such stress. Although there 
are many different experimental protocols currently employed, the UCMS has emerged as a 
relevant and reliable tool for reproducing behavioural and physiological symptoms of poor mental 
health. Various observational (i.e. the reward and splash test) and molecular tests (i.e. plasma 
corticosterone levels) exist to confirm the successful implementation of chronic stress. 
Additionally, a large degree of variability exists amongst recent studies employing non-habituating 
stress protocols. This is important to acknowledge as it dilutes the applicability of findings and 




With regards to our experiments, we initially stressed the rats during their awake phase to 
increase applicability to the human setting (Supplementary data, Figure 18-22). However, with 
the exception of attenuated antioxidant capacity (Figure 22), we observed no changes in our other 
biochemical measures. Although our second experimental run was largely similar to previous 
UCMS studies (Table 5), some differences in our protocol persisted. For example, we only 
stressed our rats once per day and employed a total of six stressors. Other UCMS protocols 
exposed their rodents to two stressors per day and utilized a minimum of eight stressors or more 
(Table 5: studies 1-4; 10; 13; 17-19). We did not perform behavioral assessments due to the 
extensive validation of the protocol however, some of our findings were unexpected (ACTH and 
corticosterone) and this emphasizes the importance of these tests. In light of this, we propose 
that it may be useful to do a comprehensive analysis of all studies completed thus far with the aim 
to develop a specific set of guidelines/standards for the UCMS model that in turn should enhance 




Table 5: Summary of findings from studies that employed the UCMS model. Unless otherwise stated, animals were stressed 
during their sleep phase (lights on). Stress groups were housed individually and animals had ad libitum access to standard chow and 
water. 
Study # Stressor regimen Animals used Investigated site Observations Reference 
1 
Mice were exposed to 11 different 
stressors (multiple stressors/day) for 7 
weeks.  
Euthanasia: - 
Intervention: Agomelatine (10 mg/kg), 
melatonin (10 mg/kg) and fluoxetine (15 
mg/kg) for 5 weeks.  
Male inbred 
Balb/c ByJ mice 
(9-10 weeks old). 
Plasma. ↑ ACTH; ↑ corticosterone, ↑ 
IL-6; ↑ TNF-α.  
Pharmaceutical interventions 
prevented behavioural deficits 
in grooming, attack frequency, 
and immobility time as well as 
increases in biochemical 
markers.  
(Mutlu et al., 
2013) 
2 
Mice were exposed to 11 different 




Balb/c ByJ mice 
(9-10 weeks old). 
Plasma. ↑ ACTH; ↑ IL-6; ↑ TNF-α. 
Tianeptine, olanzapine and 
fluoxetine abolished stress-
induced reductions in coat 
state, grooming and attack 
frequency. These drugs 





Intervention: Tianeptine (5 mg/kg), 
olanzapine (2.5 mg/kg) and fluoxetine 
(15 mg/kg) for 5 weeks. 
further prevented enhanced 
plasma ACTH, IL-6 levels and 
TNF-α levels.   
3 
Rats were exposed to 7 different 
stressors (three stressors/day) times per 
day, for 21 days. 
Euthanasia: - 
Intervention: Electroacupuncture. 
Male Wistar rats 
(150-170 g). 
Plasma. ↑ ACTH; ↑ corticosterone. 
Intervention reduced 
behavioural and physiological 
markers of stress to normal.  
(Liu et al., 
2013) 
4 
Mice subjected to unpredictable chronic 
stress regime (10 different stressors) for 
14 days with one stressor/day.  
Euthanasia: - 
Male ApoE-/- mice 








↓ Body weight; ↑ intimal 
VCAM-1 and ICAM-1 
expression; ↑ C-reactive 
protein and IL-6; ↑ plaque 
size. 
(Zhang et al., 
2010) 
5 
Mice exposed to five different stressors 






aorta and urine.  
↓ Body weight; ↓ urinary 
corticosterone; no difference 






Housing: Individually or in groups of 
four. 
Euthanasia: Sodium pentobarbital. 
Diet: standard 
diet or high salt 
diet. 
levels; ↑ heart rate and blood 
pressure. 
6 
Mice subjected to six different stressors 
for 1, 3 or 6 weeks (depending on 
strain). 









root and bone 
marrow. 
No differences in body weight; 
↑ leukocytes, monocytes and 
neutrophils in blood and in 
intima; ↑ NE. 
(Heidt et al., 
2014) 
7 
Mice experienced 2-4 socio-
environmental stressors/day for eight 
weeks.  
Euthanasia (ELISA): CO2 asphyxiation 
and decapitation. 








No differences in body weight; 
↑ in total corticosterone levels; 
no differences in Phe-induced 
vasoconstriction; ↓ ACh-
induced vasodilation and ↓ 
maximal response to ACh.  






Rats subjected to two weeks of 
randomized social stressors.  
Housing: Five rats per cage. 











↑ Plasma corticosterone; ↓ 
brain and cardiac NO 
synthesis; initially no 
differences in aortic NO ACh-
dependent vasodilation 
however, two-weeks post 
stress: ↓ aortic NO production 




Exposure to seven different stressors for 
eight weeks. 







No differences in Phe-induced 
vasoconstriction; ↓ 
methacholine-induced 
vasodilation; no differences in 
arterial expression of eNOS; ↓ 








Mice exposed to 4 weeks of UCMS 
protocol (8 stressors). 
Euthanasia: Sodium pentobarbital. 
Intervention: iNOS inhibitor.  
9-week-old male 




↑ Levels of iNOS mRNA in 
cortex, ↑ nitrite in plasma, ↓ 
Nissl bodies; ↑ neuronal cell 
damage.  
Effects ameliorated with iNOS 
inhibitor.  
(Peng et al., 
2012) 
11 
Rats experienced 6 different stressors 
for 3 weeks of an 8-week period. Rats 











↑ Plasma corticosterone, ↑ 
sensitivity to Phe-induced 
vasoconstriction.  
(Neves et al., 
2009) 
12 
Rats subjected to 8 weeks of UCMS (7 
different stressors). 






Both males and females 
demonstrate ↓ vasodilation 
following methacholine, ↓ NO 
levels and ↑ H2O2 in 
vasculature; ↑ corticosterone 





levels in both males and 
females. 
13 
Rats exposed to 8 weeks of UCMS (9 
different stressors).  
Euthanasia: - 
Intervention: Etanercept. 
Adult male Wistar 
rats (250-300 g). 
Thoracic aorta. ↓ Body weight; no differences 
in blood pressure; ↓ eNOS; ↓ 
endothelium-dependent 
dilation.  
Effects abolished by 
etanercept. 
(Bayramgurler 
et al., 2013) 
14 
Mice subjected to two, 2-week UCMS 
protocols (5 different stressors), 
separated by an interval of 6 weeks.  
Euthanasia: Sodium pentobarbital. 
Intervention: Fluoxetine. 
Male BALB/c 
mice (7-9 weeks 
old). 
 
Thoracic aorta. No differences in body weight; 
↑ depressive behaviour; ↓ NO-
dependent relaxation; ↑ 
atheroma.  
Effects abolished by 
fluoxetine treatment. 
(Isingrini et al., 
2012) 
15 
Rats exposed to 6 different stressors, 
twice a day, for 6 weeks. 
Housing: - 




↑ NO levels in females 
compared to males; females 
had ↓ ICAM-1 levels, ↑ GPx 
activity and ↓ SOD activity 





Euthanasia: Decapitation compared to males; ↑ 
malondialdehyde.  
16 
Mice were subjected to variable 
stressors (one stressor/day) for 21 days.  
Euthanasia: Decapitation. 
Intervention: Bilberry extract, fluoxetine 
(10 mg/kg), L-arginine (125 mg/kg) and 
L-NAME (10 mg/kg) were administered 
daily for 21 days. 
Male Laca mice 
(20–30 g). 
Brain. ↑ Lipid peroxidation; ↑ nitrite; ↓ 
glutathione; ↓ SOD; ↓ 
catalase. 
Bilberry extract reversed 
expression of these 
parameters to baseline.  
 
(Kumar et al., 
2012) 
17 
Mice were exposed to 12 different 
stressors for 6 weeks. 
Euthanasia: -  
Intervention: Liquiritigenin (7.5 and 15 
mg/kg) and fluoxetine (20 mg/kg). 




↑ Corticosterone; ↓ 
glutathione; ↓ SOD. 
These parameters returned to 
baseline following 
administration of liquiritigenin 
and fluoxetine.  






Mice experienced 9 different stressors 
(one stressor/day) for 2 weeks.  
Euthanasia: Decapitation under 
anesthesia. 
Intervention: Methyl jasmonate (5, 10 
and 20 mg/kg). 
Male Swiss mice 
(23.5 ± 1.5 g). 
Serum and brain. ↑ Corticosterone; ↓ 
glutathione; ↓ SOD; ↑ 







Rats were subjected to 10 different 
UCMS stressors (1-3 stressors/day), for 
6 weeks.  
Euthanasia: Anesthetized and 
transcardially perfused. 
Intervention: Argan oil. 
Male and female 
Wistar rats (34 ± 





↑ Corticosterone; ↑ NO; ↑ 
MDA; ↓ SOD; ↓ catalase; ↑ 
lipid peroxidation  
Argan oil returned all 
behavioural and physiological 
measurements to normal.  
(Hicham et al., 
2018) 
20 
Rats subjected to 10 days of UCMS (6 
different stressors).  
Euthanasia: - 




- ↓ Food consumption; ↓ growth 
rate; ↓ water consumption; ↓ 
activity; ↓ grooming.  





4.2 UCMS decreased plasma ACTH levels 
Our data revealed that the UCMS protocol resulted in decreased plasma ACTH levels, with 
no changes in corticosterone or epinephrine concentrations (Figure 8-10). This was 
unexpected as previous UCMS studies largely showed increased plasma ACTH (Table 5: 
studies 1-3) and corticosterone levels (Table 5: studies 1; 3; 7; 8; 11-12; 18-19). This could be 
due to differences in stressor severity, frequency and duration as well as differing methods of 
euthanasia. Interestingly, studies primarily employing decapitation, with or without anesthesia 
or carbon dioxide asphyxiation noted differences in plasma corticosterone levels (Table 5: 
studies 1; 3; 7; 8; 11-12; 18-19). Some terminated the animals using an intraperitoneal 
injection of sodium pentobarbital and found no differences in plasma corticosterone, however 
they did observe alterations in urinary corticosterone levels (Bernberg et al., 2009). This 
highlights the impact of varying methods of euthanasia on systemic concentrations of stress-
related hormones. 
As we suspected an injection of sodium pentobarbital may recruit neuroendocrine stress-
response mechanisms, we instead measured plasma ACTH and corticosterone levels in blood 
that was drawn a week prior to the end of the UCMS protocol. However, it is likely that this 
blood draw was itself a stressful experience as it occurred in a room the rats were unfamiliar 
with, they were handled for a brief period of time by a trained professional the rats were not 
habituated to, and it is possible that the rats were aware of themselves losing their inhibitions. 
Activation of the stress response would have upregulated HPA axis and SNS activity, 
culminating in a surge of glucocorticoids and catecholamines into systemic circulation.  
The lack of differences in corticosterone levels together with reduced ACTH concentrations 
may be representative of either hypersensitization of the adrenal cortex to ACTH or, enhanced 
negative feedback capabilities of corticosterone on the hypothalamus and pituitary gland. 
Because this is a unique finding compared to other UCMS protocols, further research is 
required to determine which of these hypotheses may be more plausible. However, a 




patients with stress-related psychiatric disorders often demonstrate moderately reduced or no 
changes in corticosterone levels (Yehuda and Seckl, 2011). This theory proposes that chronic 
stress exposure upregulates glucocorticoid receptor expression which sensitizes HPA axis 
negative feedback inhibition. Furthermore, impaired glucocorticoid catabolism may ensue, 
increasing the active period of cortisol. Thus, downstream glucocorticoid-mediated 
pathologies may still arise despite no changes in circulating plasma levels (Yehuda and Seckl, 
2011). Contrastingly to depressed individuals, patients with PTSD typically present with 
reduced HPA axis activity. We thus speculate that the rats in our study may be exhibiting 
symptoms of PTSD rather than depression however further studies are required to confirm 
this. Lastly, we recommend follow-up studies also investigate GR expression in the 
hypothalamus and pituitary gland as well as the presence of morphological changes to adrenal 
tissue, such as hyperplasia or hypertrophy.   
Corticosterone can also be measured in a variety of other sources e.g. saliva, urine, hair or 
faeces (Golbidi et al., 2015). Although salivary glucocorticoids function as a marker of acute 
HPA axis activity, this method is beneficial because extracting saliva does not induce pain or 
discomfort in subjects. Furthermore, samples may be stored at room temperature for up to 
four weeks (Bozovic et al., 2013). By contrast, hair glucocorticoid concentrations reflect long-
term stress levels as human hair grows at a rate of approximately 1 cm/month (Golbidi et al., 
2015). The measurement of fecal corticosterone metabolites was also identified as an 
attractive non-invasive option for the long-term assessment of glucocorticoid levels (Thanos 
et al., 2009). Notably, acute stress responses and diurnal variations have limited influence on 
hair and fecal glucocorticoid measurements (Meyer et al., 2014). Thus, we recommend 
assessing hair and fecal corticosterone levels at the beginning and end of the experimental 
procedure.  
Taken together, our data highlights the variable nature of the UCMS model and the lack of a 
standardized approach.  Moreover, it is likely that our current model is simulating PTSD 




that the model can be further refined in terms of the measurement of stress biomarkers. Here 
corticosterone levels should ideally be measured at multiple time-points and in different 
sources to gain a better understanding of glucocorticoid concentrations over the course of the 
entire experimental procedure and the choice of euthanasia be carefully considered.  
4.3 Chronic stress impaired aortic vasodilation 
Our findings show impaired endothelium-dependent dilation together with no observed 
differences in vasoconstriction (Figures 12-16) which is in agreement with most studies (Table 
5: studies 7-9; 12-14). However, others have shown increased sensitivity to Phe-induced 
vasoconstriction (Neves et al., 2009).  The ability of ACh to induce vascular smooth muscle 
cell relaxation is heavily influenced by the integrity of the endothelium (Fuchgott and Zawadski, 
1980). As no signs of endothelial damage were observed (Figure 11) and because of the 
essential vasodilatory properties of NO, impaired vasorelaxation is likely due to decreased NO 
bioavailability. This suggests that chronic stress may impair endothelial function by depleting 
NO levels. Reduced NO bioavailability could be a consequence of limited availability of L-
arginine, eNOS uncoupling or inhibition as well as increased NO degradation 
(Malekmohammad et al., 2019). Aside from the eNOS-inhibiting effects of glucocorticoids, the 
SNS induces drastic increases in heart rate and blood pressure, which may further impact the 
integrity of the endothelium and contribute towards endothelial dysfunction (Nickel et al., 
2009). However, we observed no differences in ET-1 which is a marker for endothelial damage 
(Figure 11) (Fox et al., 2018). Glucocorticoid synthesis-inhibitors improve endothelium-
dependent dilation by increasing NO levels (Broadley et al., 2005, 2006). Glucocorticoids and 
catecholamines can further induce a dysregulated proinflammatory and prooxidative state 
which can potentiate endothelial dysfunction (Zielińska et al., 2016; Burford et al., 2017).   
4.4 UCMS attenuated vascular SOD activity 
Increased oxidative stress represents an important avenue for the development of endothelial 
dysfunction. A dysregulated oxidative state is often a result of increased free radical production 




noted decreased SOD activity and no significant differences in NOX activity following eight 
weeks of UCMS (Figure 17). This finding is supported by a number of recent studies (Table 5: 
studies 17-19). As NOX contributes to SO formation and SOD catalyzes the conversion of SO 
into hydrogen peroxide, blunted SOD activity suggests elevated vascular SO. Superoxide is a 
potent free radical and is directly implicated in the onset of endothelial dysfunction primarily 
via eNOS uncoupling (Santilli et al., 2015; Incalza et al., 2018). This occurs as a result of 
oxidation of tetrahydrobiopterin, an important eNOS cofactor. Following this, dysfunctional 
eNOS synthesizes less NO and this may explain our finding of impaired endothelium-
dependent dilation. However, in the presence oxidative stress both increased and decreased 
eNOS activity were reported (Kamper et al., 2009; Hicham et al., 2018). This may be a 
compensatory mechanism whereby eNOS attempts to increase its activity to produce more 
NO in the hope of maintaining endothelium-dependent vasodilation (Isingrini et al., 2012). 
Furthermore, others found no correlations between oxidative or inflammatory markers with 
blunted endothelial function (D’Audiffret et al., 2010). Given that the pathological effects of 
stress on the body are heavily influenced by the manner in which stressors are perceived, and 
thus the degree of upregulation of stress-response mechanisms, this suggests that vascular 
dysfunction induced by the UCMS may not be a consequence of more common culprits, but 
may be due to mechanisms yet to be identified. 
4.5 Rats were age-matched but not weight-matched  
Although the rats in the beginning of our study were aged-matched, they were not weight-
matched (Figure 5).  This was unfortunate and only detected at the end of our experimental 
run.  To determine whether this would have an impact on our biochemical measures (Figure 
8-17), we consulted with a statistician (Prof Martin Kidd). Here we first checked to determine 
whether body weight correlated with any of our findings. We thereafter performed an analysis 
of covariance (with body weight as the covariate) to detect whether body weight affected our 




Although we acknowledge this as an unfortunate limitation of our study, the results of the 
statistical analyses corroborate our findings. In support, a number of studies found alterations 
in corticosterone concentrations as well as impaired endothelium-dependent dilation with no 
differences in body weight (Table 5: studies 7; 13-14). The Stress group in our study 
demonstrated an increased growth rate compared to Controls (Figure 6) that is opposite to 
Farhan et al. (2014) who attributed a reduced growth rate to the onset of depressive-like 
behaviours. However, because the Stress rats weighed less from the beginning of the 
experimental procedure, their increased growth rate likely occurred as there was more scope 
for them to grow compared to Controls, or because they displayed increased food intake at 
weeks 5, 6 and 8 (Figure 7).    
4.6 Limitations 
Despite our best efforts to improve upon our first experimental protocol, our second study is 
not without its own limitations. These include age-matched but not weight-matched 
experimental groups as well as the lack of standard behavioural assessments (reward test, 
splash test, novelty suppression test, immobility test). Despite this, we did assess coat 
condition at the end of each week.  A score of 0 or 1 was assigned to the body part of each 
rat if said part was either clean or dirty. However, because this was assessed without an 
intervention (such as a spray of sucrose-water), grooming score more accurately reflected the 
cleanliness of the cage, as opposed to the rats’ motivational behaviour. Control rats were also 
housed two-per-cage and thus their coats were often in better condition because they were 
able to groom each other.  
We also measured the blood pressure and heart rate of each rat at the start, middle and end 
of the UCMS protocol. However, this measurement was flawed as it involved restraining the 
rats in a transparent Perspex tube. Restraining the rats in this manner is a stressful experience 
and thus our results did not accurately reflect blood pressures for the duration of the protocol.  
As we also experienced technical difficulties with the blood pressure apparatus these data 





In summary, our results provide further support for the role of chronic stress in potentiating 
CVD. Following eight weeks of UCMS, we observed impaired endothelium-dependent dilation 
which is potentially a result of increased oxidative stress. Due to the damaging nature of this 
free radical, dysregulated SO concentrations can promote endothelial dysfunction via eNOS 
uncoupling and downregulated NO levels. This study highlights the importance of healthy 
coping mechanisms in reducing the onset of not only poor mental health, but cardiovascular 
derangements too. Thus, we propose a push for the integration of psychiatric therapies 
together with established cardiovascular risk-reducing behaviors. Education programs should 
focus especially on youth development within this context as adoption of healthy strategies 
from a younger age will ensure lasting changes to the state of stress in SA.  
5.1 Future directions 
We propose that future studies investigate the effects of UCMS stressors during the awake 
phase as rodents have evolved to respond to stressors during a state of consciousness.  This 
will increase the translation of findings to the human context.  
We further suggest that a “gold standard” for the UCMS protocol, i.e. in terms of stressor types, 
severity, frequency and duration should be established. Stress as a pathological stimulus is 
already an abstract and difficult-to-assess risk factor for disease progression, while its 
downstream negative effects are further confounded by the heterogenous manner whereby 
organisms perceive and subsequently adapt to such stressors. Limiting this variability should 
enhance the applicability and translation of results from animal models of chronic stress into 
the clinical context.  
Future research work should also focus on identifying and confirming mechanisms of reduced 
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The protocol for the following ELISAs (Elabscience Biotechnology Inc, Houston TX) will be 
discussed concurrently due to identical methodology: ACTH (E-EL-R0048), corticosterone 
(E-EL-R0269), and E (E-EL-0045). The ET-1 kit (E-EL-R1458) was conducted in a slightly 
different manner and will thus be separately discussed.  
Reagent preparation: ACTH (E-EL-R0048), corticosterone (E-EL-R0269) and E (E-EL-
0045). 
All reagents were brought to room temperature (18-25°C) before use.  
1. Wash buffer (750 mL): 30 mL of Concentrated Wash Buffer was diluted with 720 mL 
of deionized water. 
2. Standard working solution: After centrifuging (Boeco M240, Hamburg, Germany) 
for 1 minute at 10, 000 x g, 1 mL of Reference Standard and Sample Diluent were 
combined to produce a 1, 000 pg/mL working solution. Serial dilutions were then 
prepared with the following dilution gradient: 1, 000, 500, 250, 125, 62.5, 31.25 and 0 
pg/mL.  
3. Biotinylated Detection Ab working solution: A 1x working solution was prepared 
with the Biotinylated Detection Ab Diluent (50 µL/well). 
4. Concentrated HRP Conjugate working solution: A 1x working solution was 
prepared using the Concentrated HRP Conjugate Diluent (100 µL/well).   
Assay procedure: ACTH (E-EL-R0048), corticosterone (E-EL-R0269) and E (E-EL-
0045). 
1. The varying concentrations of the Standard Working Solution were added in 
duplicate (50 µL/well). 50 µL of sample was then added to the remaining wells, also 




immediately added to each well (50 µL/well). A sealer was used to cover the plate 
before it was then incubated at 37°C for 45 minutes. 
2. 350 µL of Wash Buffer was then added to each well and allowed to soak for 1-2 
minutes. This wash step was repeated 3 times.  
3. HRP Conjugate working solution was then added (100 µL/well), the plate covered 
with a sealer and subsequently incubated for 30 minutes at 37°C.  
4. The plate was then washed 5 times as conducted in step 2. 
5. 80 µL of Substrate reagent was then added to each well before incubating the plate 
at 37°C for another 15 minutes.  
6. Following the final incubation step, 50 µL of Stop Solution was pipetted into each 
well.  
7. The optical density was then determined immediately using a micro-plate reader (EZ 
Read 400 Microplate reader, Biochrom, Holliston MA) set to 450 nm.  
Reagent preparation: ET-1 kit (E-EL-R1458) 
All reagents were brought to room temperature (18-25°C) before use.  
1. Wash buffer (750 mL): 30 mL of Concentrated Wash Buffer was diluted with 720 mL 
of deionized water. 
2. Standard working solution: After centrifuging (Boeco M240, Hamburg, Germany) 
for 1 minute at 10 000 x g, 1 mL of Reference Standard and Sample Diluent were 
added to produce a working solution of 1000 pg/mL. Serial dilutions were then 
prepared with the following dilution gradient: 1000, 500, 250, 125, 62.5, 31.25 and 0 
pg/mL.  
3. Biotinylated Detection Ab working solution: A 1x working solution was prepared 




4. Concentrated HRP Conjugate working solution: A 1x working solution was 





Assay procedure: ET-1 kit (E-EL-R1458) 
1. The varying concentrations of the Standard working solution was added in duplicate 
(100 µL/well). 50 µL of sample was then added to the remaining wells, also in 
duplicate (100 µL/well). The plate was then covered an incubated at 37°C for 90 
minutes.  
2. The solution was subsequently removed and 100 µL of Biotinylated Detection Ab 
working solution was added to each well before another incubation period of 1 hour.  
3. 350 µL of Wash Buffer was then added to each well and allowed to soak for 1-2 
minutes. This wash step was repeated 3 times.  
4. HRP Conjugate working solution was then added (100 µL/well), the plate covered 
with a sealer and then it was incubated for 30 minutes at 37°C.  
5. The plate was then washed 5 times as conducted in step 2. 
6. 90 µL of Substrate reagent was then added to each well before incubating the plate 
at 37°C for another 15 minutes.  
7. Following the final incubation step, 50 µL of Stop Solution was pipetted into each 
well.  
8. The optical density was then determined immediately after with a micro-plate reader 





This appendix details the protocol used for the dissection of rat aortas and the assessment 
of endothelial function.  
Reagent preparation 
KH buffer, Phe and ACh was made fresh each morning according to the recipes detailed 
below.  
1. KH buffer: 
KH buffer was prepared from five individual buffers, using distilled water (dH2O) (Table 6). 
These buffers were stored at 4°C for the entire experimental procedure.  
Table 6: Individual buffers used to make KH buffer.  
Buffer Amount required 
1. NaCl  279.00 g/ 2 L  
2. NaHCO3 83.60 g/ 2 L 
3. KCl 
               KHPO4 
17.60 g/ 1 L 
8.10 g/ 1 L 
4. MgSO4.7H2O 
               Na2SO4 
7.40 g/ 1 L 
4.20 g/ 1 L 
5.            CaCl2.H2O 18.00 g/ 1 L  
  
Buffer #1, #2, #3, #4 and glucose were added to 3 L of distilled water in a conical flask. Once 
the reagents completely dissolved, buffer #5 was added and the total volume was made up 
to 5 L with dH2O. The prepared KH buffer was then filtered before use.  
1 L total  




2. 0.9% Saline solution: 9 g of NaCl was dissolved in 1 L of dH2O.  
3. Phe stock solution (1 mM): 0.002 g of Phe was dissolved in 10 mL of 0.9% saline. 
4. ACh: 
• Stock A (10 mM) - Dissolve 0.0182 g of ACh in 10 mL of 0.9% saline.  
• Stock B (1 mM) – Add 1 mL of Stock A to 9 mL of 0.9% saline. 
• Stock C (100 µM) – Add 1 mL of Stock B to 9 mL of 0.9% saline. 
Dissection procedure 
Great care was taken to not stretch or otherwise damage the aorta during the dissection 
procedure: 
1. Following the removal of the heart, the chest cavity was rinsed with approximately 5 
mL of KH buffer.  
2. Using a pair of tweezers, the aorta was gently pushed aside while the connective 
tissue between the aorta and vertebral column was dissected.  
3. The aorta was then placed in a 100 mm petri dish containing ice-cold KH buffer.  
4. All adventitia and connective tissue were subsequently removed using a magnifying 
glass. This step was carried out with care and efficiency to prevent damage to the 
endothelial cell layer and impaired vascular function.  
5. Any blood clots within the vessel were removed before a 3 mm piece of tissue from 
the center of the vessel was carefully mounted onto two steel hooks. We also 
ensured that the tension on the rig was enough to keep the aortic ring in place. 
However, this was done carefully to prevent any unnecessary stretching of the tissue.  






The temperature of the organ bath was constantly measured and maintained between 36.5 
and 37°C for the duration of the experiment:  
1. The aortic ring was afforded 5 minutes to acclimatize the oxygenated KH buffer at a 
tension of approximately 0.2 g.  
2. The tension was gradually increased to 1.5 g over the course of 30 minutes, with 
buffer changes at 10 and 20 minutes, respectively.  
3. After 30 minutes, the total volume of the organ bath was set to 25 mL exactly. 2.5 µL 
of 1 mM stock Phe solution was then added to the organ bath to induce 
vasoconstriction. Once maximal contraction had been reached (plateau), 25 µL of 
stock A ACh solution was administered.  
4. Once maximal vasodilation had been reached, the organ bath was rinsed 3 times 
with pre-warmed KH buffer and refilled to 25 mL.  
5. Another stabilization period of 30 minutes was then done at a tension of 1.5 g, with 
washing steps at 10 and 20 minutes, respectively.  
6. After 30 minutes, cumulative concentrations of Phe followed by cumulative 
concentrations of ACh was administered as follows: 
a. Phe (Total volume = 25 µL): 
i. 2.5 µL of stock  
ii. 5 µL of stock 
iii. 5 µL of stock 
iv. 7.5 µL of stock 




b. ACh (Total volume = 301.8 µL) 
i. 7.5 µL of Stock C 
ii. 17.5 µL of Stock C 
iii. 42.5 µL of Stock C 
iv. 14.3 µL of Stock B 
v. 220 µL of Stock B 
7. Once the experiment was finished, the length of the ring was measured and weighed 






This appendix describes protocols used for the SOD and NOX assays.  
SOD 
This assay measures the auto-oxidation of 6-hydroxydopamine at 490 nm for 4 minutes 
(Ellerby and Bredesen, 2000).   
Reagent preparation 
• Phosphate buffer: 50 mM Na-Pi; 0.5% (v/v) Triton X-100; pH 7.5. 
• SOD assay buffer: 50 mM NaPO4- without Triton X-100, pH 7.4. 
• 6-hydroxydopamine: nitrogen purge 10 mL MilliQ water with 50 µL perchloric acid 
for 15 minutes. Use 10 mL of this and add 4 mg 6-hydroxydopamine to this solution. 
Wrap in foil and store on ice. 
•  DETAPAC: 0.4 mg in 10 mL of SOD assay buffer. Store at -20°C.  
Tissue sample preparation 
1. Approximately 100 mg of tissue was combined with 1 mL of phosphate buffer and 
homogenized using a Bullet Blender (Next Advance, Troy NY) (speed setting of 8) for 
five times one-minute periods, with a minute interval in between.  
2. The homogenate was then sonicated (Misonixa ultrasonic liquid processor S-4000, 
Hielscher, Germany) (at amplitude setting of 10) for 10 seconds.  
3. Sample was then centrifuged (Boeco M240, Hamburg, Germany) for 10 minutes at 
15, 000 x g at 4°C.  
Assay procedure 
1. dH2O acted as the blank and 12 µL was added in triplicate to a clear 96-well plate.  




3. 15 µL of 6-HD was then added to each well.  
4. Lastly, 170 µL of DETAPAC was pipetted into each well to initiate the reaction.  
5. Absorbance was then measured for 4 minutes at 490 nm using a plate reader (EZ 
Read 400 Microplate reader, Biochrom, Holliston MA).  
NOX 
A modified assay was used to determine the activity of NOX (Abid et al., 2007). In this 
reaction, the NADPH oxidase complex donates electrons to lucigenin. Lucigenin in turn 
emits photons of light which was measured over 20 minutes using a luminometer (Glomax-
96 luminometer, Promega, Madison WI).  
Reagent preparation 
1. Prepare a modified assay buffer containing: 120 mM NaCl, 250 mM HEPES, 5.9 mM 
KCl, 11 mM glucose, 1.75 mM CaCl2(2H2O), 0.5 mM EDTA, 100 μM NADH and 5 μM 
of lucigenin (pH 7.4).  
Tissue sample preparation 
1. Combine 100 mg of tissue with 1 mL of phosphate buffer and homogenize using a 
Bullet Blender (Next Advance, Troy NY) (speed setting of 8) for five times one-minute 
periods, with a minute interval in between. 
2. The homogenate was then sonicated (Misonixa ultrasonic liquid processor S-4000, 
Hielscher, Germany) (at amplitude setting of 10) for 10 seconds.  
3. The sample was then centrifuged (Boeco M240, Hamburg, Germany) for 10 minutes 
at 15, 000 x g at 4°C.  
Assay Procedure 
1. 100 µL of sample and 100 uL of assay buffer were added (in duplicate) to each well 




2. The reaction was then measured every 5 minutes over a total period of 25 minutes at 











This section includes all results obtained from the first experimental run – jointly completed by 
Lucien Sher and Lukas Olivier (during the first year of the respective MSc studies).  
1. Baseline measurements 
1.1 Body weight 
At the end of each week, the body weight of each rat was measured (Figure 18) with the 
incremental weight gain expressed as a percentage of the rat’s original weight (Figure 19). No 
significant differences in body weight or percentage weight gain was noted over the eight-
week period.  
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Figure 18: Weekly body weight measurements. Data displayed as mean ± SEM; statistical 
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Figure 19: Percentage growth over the eight-week period. Data displayed as mean ± SEM; 
statistical analyses: repeated measures, two-way ANOVA, Bonferroni post hoc; n = 9. 
1.2 Food Consumption 
Food consumption was calculated by weighing the remaining pellets at the end of each week. 
Data shows that the Control group consumed more food than the Stress group during the first 
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Figure 20: Amount of food consumed per week for each group. Data displayed as mean 
± SEM; statistical analyses: repeated measures, two-way ANOVA, Bonferroni post hoc; n = 9.  
2. ELISAs 
ELISAs were obtained (Elabscience Biotechnology Inc, Houston TX) for the measurement of 
corticosterone (E-EL-R0269) and interleukin-6 (IL-6) (E-EL-R0015). 
2.1 Corticosterone 
Following the upregulation of the HPA axis, corticosterone is released from the zona 
fasciculata of the adrenal cortex. Corticosterone was measured in the plasma (Figure 21A) 
and in the left adrenal gland (Figure 21B) to discern circulatory glucocorticoids levels and to 
indirectly measure the production of corticosterone by the adrenal cortex. No significant 



























































Figure 21: Corticosterone levels were assessed as a measure of HPA axis activity. For 
both figures (A and B), data displayed as mean ± SEM; statistical analyses: unpaired t-test; n 
= 9. 
3. Oxidative stress 
Oxidative stress is regarded as one of the primary mechanisms whereby stress-mediated 
molecular damage may occur (Incalza et al., 2018).  
Evidence also shows that the liver is particularly susceptible to an increased free radical load, 
thus also likely to show the first signs of oxidative damage compared to other tissues (Li et al., 
2015). Given that our initial protocol was relatively mild, and that the primary aim of this 
experiment was to successfully establish the UCMS model and induce a phenotype of chronic 
stress, we investigated the oxidative status of the liver.  
Conjugated dienes and thiobarbituric acid reactive substances are early- and late-stage 
markers of free radical-induced lipid peroxidation. Although no significant differences were 
noted for this measurement (Figure 22A and B), we did observe a reduced antioxidant capacity 
of the Stress group when compared to Controls (Figure 22C). Glutathione is an essential anti-
oxidant capable of preventing oxidative damage to a number of cellular structures and the 




al., 2005). However, we observed no differences in the ratio of reduced:oxidized glutathione 
levels in liver tissue (Figure 22D).  
 














































































Figure 22: Analysis of various markers of oxidative stress in liver tissue. All data 
displayed as mean ± SEM; statistical analyses: unpaired t-test; n = 9. CDs - conjugated dienes; 
TBARS – thiobarbituric acid; ORAC – oxygen radical absorbance capacity; GSH – reduced 
glutathione; GSSG – oxidized glutathione. 
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